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Reactive oxygen species can target nucleobases of DNA and RNA. One of the 
major products of oxidation of nucleic acids by ROS is 8-oxo-7,8-dihydroguanine (OG) 
which is prone to further oxidation to yield the two hydantoin lesions, 5-
guanidinohydantoin (Gh) and spiroiminodihydantoin (Sp). These three lesions are 
mutagenic and their occurrence can significantly affect normal cell functions or cell 
survival. The OG, Gh, and Sp are thus removed from DNA and RNA and then are 
excreted from the cells in the form of free nucleobases. Concentrations of these species 
increase during oxidative stress and can be used as an indicator of this condition. The first 
part of this dissertation is devoted to development of aptamer-based sensors that can be 
used for detection of Gh in the free base form. We described synthesis of Gh and used an 
attachment-free SELEX method for in vitro selection of aptamers for the hydantoin. 
Recent studies have shown that OG can play a regulatory role in both DNA and 
RNA. However, if oxidation of guanine in nucleic acids plays a regulatory role, it has to 
be directed toward specific sites. Testing whether this is true can be greatly facilitated by 
mapping positions of oxidation sites. The second part of this dissertation is focused on 
investigating whether sequencing of cDNA after reverse transcription (RT) of a target 
RNA can be used for mapping oxidation sites. In order to do so, we first studied the 
composition of canonical bases that are inserted opposite OG, Gh, and Sp in RNA by RT 
enzymes. We have found that SuperScript III is capable of efficiently bypassing the 
iv
studied lesions resulting in insertion of a mixture of A and C opposite OG and mixture of 
A and G opposite Gh and Sp. These data indicated that reverse transcription of oxidized 
bases is a viable approach for mapping their positions in RNA. Additionally, we have 
completed the work required to quantify the mutation signature of oxidized lesions using 
Illumina sequencing and studied the dependence of the efficiency of deletion bypass of 
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Multiple different reactive oxygen species (ROS), such as singlet oxygen (1O2), 
hydroxyl radical (˙OH), or hydrogen peroxide (H2O2), are produced in human cells every 
day. ROS are formed during metabolism as a byproduct or induced by exogenous sources, 
such as UV radiation and environmental toxins (Figure 1.1).1-4 These unstable molecules 
may react with proteins or DNA and RNA leading to modifications of nucleobases, strand 
breaks, and inter-, or intramolecular cross-links.5-7 Occurrence of oxidative damage 
presents a significant challenge for cell survival, and over the course of evolution multiple 
mechanisms of repair (DNA and RNA) or selective degradation (RNA and proteins) of 
damaged biopolymers have been selected.8-11 Under normal conditions, there is a balance 
between damage and repair; disruption of this balance caused by overproduction of ROS 
or deficiency in repair leads to a condition called oxidative stress.12 Under oxidative stress, 
cells do not have sufficient capacity to repair oxidative damage, which results in 
accumulation of the products of oxidative damage. This in turn leads to arrest of multiple 
cell functions,13-15 and, ultimately, to apoptosis or irreversible mutations in the genetic code 
during replication due to improper readout from damaged DNA sites.15, 18 Possible long-























Among the nucleobases of DNA and RNA, guanine has the lowest redox potential 
at 1.29 V vs NHE, which makes it the major target for oxidizing agents.19 One-electron 
oxidation of guanine leads to formation of guanine radical cation (G˙+) that can act as an 
oxidant for the neighboring guanines leading to transfer of the electron hole to G with the 
highest occupied molecular orbital (typically the 5’ guanine in contiguous guanine 
sequences).20-21 The acidity of the N1-H bond in G˙+ is significantly higher than in guanine, 
and G˙+ quickly undergoes deprotonation leading to the neutral guanine radical (G˙) that 
can react with a number of free radicals or electrophiles present in its vicinity such as 
carbonate  radical (CO3˙-), superoxide (O2˙-), water, or primary amines yielding C5 or C8 
guanine adducts (Scheme 1.1).22-27 
One of the most abundant DNA and RNA lesions is a product of guanine two-
electron oxidation along the C8 pathway, 8-oxo-7,8-dihydroguanine (OG).28 Each human 
cell produces several hundreds of OG lesions per day under normal physiological 
conditions, but the number can significantly increase due to disturbance in the intracellular 
redox state (oxidative stress).29 OG is a mutagenic lesion that has been found in RNA and 
DNA that can form stable base pairs with both adenine and cytosine (Figure 1.2).30-31 
Formation of an OG-A base pair is believed to be responsible for G-to-T transversions 
during DNA replication and a change in the target recognition by the seed sequence of 
miRNA.32-33 The redox potential of OG is even lower than that of guanine (0.74 V vs NHE) 




































Figure 1.2. Structures of OG-C and OG-A base pairs. 
6 
Major products of OG two-electron oxidation are two hydantoin lesions, 5-
guanidinohydantoin (Gh) and spiroiminodihydantoin (Sp).23, 26-27, 34-35 Formation of these 
lesions is highly dependent on the pH and conformation, where Gh is a major oxidation 
product in double-stranded (ds) context and at pH below 5.8 in single-stranded (ss) 
conformations, while Sp is a major oxidation product in nucleosides, single-stranded, and 
G-quadruplex conformations and at pH above 5.8.21, 36-39 Formation of both hydantoin 
lesions leads to creation of a new stereocenter, and thus, they are synthesized as a mixture 
of enantiomers (free base) or diastereomers (nucleoside/tide). However, only the 
stereoisomers of Sp are conformationally stable, while Gh stereoisomers exist in an 
equilibrium state and easily interconvert. Absolute R and S configurations for Sp 
diastereomers have been recently assigned by the Burrows laboratory.40 Another 
interesting aspect is that Gh exists in equilibrium with iminoallantoin (Ia) with the ratio of 
the two being dependent on the pH.41 Gh and Sp have been observed in cellular DNA and 
RNA oligonucleotides and are mutagenic due to their base pairing preference for adenine 
and guanine leading to G-to-T and G-to-C transversions.34, 42-49  
 
RNA oxidation and its consequences 
Oxidative damage to RNA has not been studied as extensively as oxidative damage 
to DNA. Thus, when talking about oxidative damage to RNA it is essential to draw parallels 
between DNA and RNA. To do that, we first have to discuss the relative quantities of DNA 
and RNA in cells. About 90% of cellular RNA is directly involved in protein synthesis 
[ribosomal RNA (rRNA), transfer RNA (tRNA), and messenger RNA (mRNA)]. Thus, the 
ratio of RNA to DNA in cells is highly dependent on cell type, the rate of cell division, and 
7 
the cell cycle phase.50-52 Among normal human cells the lowest RNA:DNA ratio is 
observed in blood cells (0.11-0.36)53-54 with RNA:DNA ratio in other cell types being 
within the range of 1-2 (Table 1.1).55-57 Cancerous cells have higher RNA:DNA ratios that 
can be as high as 4 in malignant tumors.52, 57  
There are three studies of the amount of OG in RNA that can be used to assess 
relative quantities of OG in RNA and DNA. Based on the data reported, OG in RNA is 2-
25 times more abundant than in DNA (up to 5 OG molecules per 105 guanine residues in 
RNA).45, 58-59 Such a wide range in OG concentration is caused by different cell types 
(normal lung,58 colon,45 and liver45 tissue and HeLa cells59) and the detection methodology 
used. While in all these studies, DNA and RNA are digested down to nucleosides followed 
by their analysis via liquid chromatography-mass spectrometry (LC-MS), only in the study 
by Mangerich et al., has the background level of OG in DNA and RNA been measured; in 
the other two studies, formation of OG has been induced by treating cells with hydrogen 
peroxide.45, 58-59 Based on results from these reports and considering that there can be as 
much as 4 times more RNA than DNA in cells, the amount of OG in RNA could be 100-
times higher than in DNA.  
One of the reasons why for a long time oxidation of RNA has been overlooked is 
the transient nature of RNA molecules. Genomic DNA (gDNA), the sole carrier of genetic 
information in cells, is replicated only in the cells that enter the DNA synthesis phase (S-
phase) during cell division, while under normal circumstances in eukaryotes, there is only 
one copy of each chromosome and a significant amount of cellular resources are devoted 
to maintaining the integrity of gDNA because accumulation of gDNA damage can be 










Noncancerous breast tumor57 2
Normal breast57 1.1
Thyroid cancer57 2.5





Normal brain (frontal cortex) 55 2.1
Normal liver56 1.4
Normal lymphocytes53 0.26




molecules, and RNA is continuously produced by transcribing DNA, as well as degraded 
by exo- and endonucleases via multiple pathways.62-66 However, RNA becomes less 
expendable when moving from lower to higher organisms. The typical range of mRNA 
half-life in bacteria is 3-8 min,67-69 while in human cells the average half-life of mRNA is 
close to 10 h,66 and half-life values for stable RNA species such as tRNA and rRNA exceed 
several days.70-72 Considering longer turnover of RNA in human cells and disruption of a 
number of cell functions caused by RNA damage, it is not surprising that recently several 
mechanisms of coping with said damage have been discovered.9, 11, 59, 73-79 The first 
mechanism is repair of damaged bases, currently only one DNA repair-associated enzyme, 
the dioxygenase AlkB that catalyzes oxidative demethylation of 3-methylcytosine (m3C), 
1-methylguanine (m1G), 3-methylthymine (m3T), and 1-methyladenine (m1A), is known 
to act on RNA.74-75, 80 The second mechanism is sequestration of damaged RNA molecules 
followed by their selective degradation. This mechanism appears to be the predominant 
pathway for RNA.11, 73 The protein that is believed to play a central role in degradation of 
OG-containing RNA is polynucleotide phosphorylase (PNPase).59, 76-78 PNPase is a 
bifunctional enzyme with 3’-5’ phosphorolytic exoribonuclease activity digesting RNA to 
diphosphates and is also capable of 3’-terminal polyadenylation of RNA.81 This protein is 
an integral part of a multiprotein complex responsible for processing and degrading RNA 
(degradosome in bacteria or exosome in archaea and eukaryotes).82-83 PNPase has been 
shown to have an increased affinity for OG-containing RNA,76 and cell viability under 
oxidative stress, as well as the amount of OG in RNA, are heavily affected by PNPase 
overexpression or knockdown.59, 77-78 Several other proteins have been identified to have 
affinity for OG in RNA: Y box-binding protein 1 (YB-1),79 splicing factor 3B subunit 4 
10 
(SF3B4),84 heterogeneous nuclear ribonucleoprotein D0 (HNRNPD),84 heterogeneous 
nuclear ribonucleoprotein C (HNRNPC),84 DAZ-associated protein 1 (DAZAP1),84 and 
ELAV-like protein 1 (ELAVL1).84 However, as of now, not enough work has been done 
to claim that they can play a role in RNA oxidative damage surveillance. Another two 
peculiar details about cellular response to RNA oxidation are that (1) levels of some OG-
binding proteins (PNPase and HNRNPD) rapidly decrease in cells under oxidative stress77, 
84 and that (2) efficient degradation of OG-containing mRNA requires removal of the 5’ 
m7GTP cap,18 meaning that it predominantly follows the 5’-3’ XRN1 digestion pathway.85  
Degradation of OG-containing RNA on its own would not be sufficient for removal 
of OG from cellular RNA because it leads to formation of 8-oxoguanosine diphosphate 
(OGDP) that could be used in RNA synthesis. Three enzymes are known to be responsible 
for removal of 8-oxo-2’-deoxyguanosine triphosphate (dOGTP) and 8-oxo-2’-
deoxyguanosine diphosphate (dOGDP) from the nucleotide pool in mammalian cells, 
reducing the probability of incorporation of OG in DNA: MutT homolog 1 (MTH1), MutT 
homolog 2 (MTH2), and NUDIX hydrolyze 5 (NUDT5).86-91 Two of them, MTH1 and 
NUDT5, have demonstrated the ability to recognize ribonucleotide triphosphates as 
substrates.91-93 MTH1 is capable of hydrolyzing 8-oxoguanosine triphosphate (OGTP) and 
OGDP with ~10-times lower catalytic efficiency than dOGTP and dOGDP.91-93 NUDT5 
has been shown to act on OGDP with ~100-times lower catalytic efficiency than on 
dOGDP.92 It is not known whether these enzymes can act on tri- or diphosphates of dGh, 
rGh, dSp, or rSp. The preference of these enzymes for di- and triphosphates of 2’-
deoxyribonucleotides can probably be justified by the fact that their concentration in  
mammalian cells is 10-100 times lower compared to their ribo counterparts.94-96 The 
11 
scheme showing the fate of different OG-containing species is shown on Figures 1.3 and 
1.4.9, 92, 97-105 It should be noted that degradation of 8- oxoguanosine (rOG) di- and 
triphosphates to monophosphates is sufficient for permanent removal of OG from the 
triphosphate pool used for RNA synthesis due to the fact that guanylate kinase (GK) does 
not act on 8-oxoguanosine monophosphate (OGMP) or 8-oxo-2’-deoxyguanosine 
monophosphate (dOGMP),97-98 and that ribo- and 2’-deoxyribonucleotide pools of OG do 
not intermix due to OGDP not being a substrate for ribonucleotide reductase (RNR).92 
Oxidative damage to RNA and its consequences have been predominantly studied 
in patients suffering from neurodegenerative diseases or severe mental illness. These 
studies revealed that these disorders cause a dramatic increase in RNA oxidation in brain 
cells without a significant increase in DNA oxidation.14, 16, 106-111 This phenomenon can be 
in part attributed to the high affinity of RNA for multiply charged metal cations combined 
with an increased concentration of redox-active iron associated with neurodegenerative 
disease.14, 112-114 It has been shown that accumulation of OG in rRNA and mRNA results 
in severe disruption of protein synthesis (translation stalling and production of truncated or 
erroneous proteins),14, 18, 108-111 while OG in microRNA (miRNA) could change their target 
preference due to the ability of OG to form a stable OG-A base pair.32, 115 
 
Detection of OG expelled from RNA and DNA 
Expulsion of OG from DNA and RNA yields four different species, OG free base 
from base excision repair (BER) of DNA,103-105 dOGMP from digestion of oligonucleotides 
produced during nucleotide excision repair (NER),105, 116 OGMP from hydrolytic cleavage 















Figure 1.3. Origin and fate of OG in RNA. On the figure PNP – purine nucleoside 















Figure 1.4. Origin and fate of OG in DNA. On the figure PNP – purine nucleoside 
phosphorylase, NDPK – nucleoside-diphosphate kinase. 
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1.3 and 1.4).77, 117 In addition to that, OG is also produced from oxidation of guanine in the 
nucleotide pool.118-119 Mono-, di-, and triphosphates containing OG are then digested to 
rOG and dOG that together with the OG free base can be excreted from cells.92, 99, 101, 104-
105 Currently, there is no information available on excretion of Sp or Gh from cells. OG-
containing species excreted from cells have been used as a biomarker of oxidative stress 
for over two decades.120-123 Typically OG, dOG, and rOG are quantified in a blood or urine 
sample using either chromatographic methods or enzyme-linked immunosorbent assay 
(ELISA) with antibodies specific for OG.120, 122-129 Alternatively to antibodies, aptamers, 
DNA or RNA oligonucleotides that can specifically bind to a target molecule can be used 
for detection of OG or products of its oxidation. Aptamers have a number of advantages 
when compared to antibodies such as a longer shelf-life, lower cost, and significant 
structural changes induced by target binding that allow designing of complex sensors that 
can be used in vivo (Figure 1.5).130-137 Most importantly, antibodies can only be developed 
for the immunogenic target molecules, which is one of the reasons why there are no known 
antibodies for Gh or Sp nucleobases or nucleotides. This topic is covered in more detail in 
Chapter 2. 
 
Possible regulatory role of RNA oxidation 
Recent studies have shown that RNA oxidation does not occur randomly and could 
potentially be directed toward specific RNA molecules or sites in these molecules.108-111, 
138-143 This suggests that oxidation of RNA may not only result in arrest of normal cell 
functions, but also change the existing regulatory role of the oxidized RNA or provide it 


















Figure 1.5. Example of a simplistic aptamer-based sensor. In the figure T = target 
molecule, F = fluorophore, Q = quencher. 
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existing mature RNA into shorter functional RNAs,138-143 or a change in conformation or 
base-pairing preference of RNA upon oxidation (Figure 1.6).32, 144 The first mechanism has 
been observed for selective fragmentation of tRNA141-143 and mRNA.139 Oxidative damage 
is one of the factors that ultimately induces enzymatic cleavage in the anticodon loop and 
division of the original tRNA into 5’ and 3’ halves recently named tiRNA.138, 141 Such 
molecules with several smaller fragments of tRNA (tRFs) have been recently shown to 
play a role in proliferation of cancer cells and the cellular stress response.138, 140-143 The 
second mechanism has been observed for changes in tRNA conformation upon methylation 
of adenine144 and for a change in the target preference upon oxidation of guanine to OG in 
the seed region of miRNA.32 The question of whether these cases are unique or there are 
systematic trends of RNA oxidation being directed toward specific sites and leading to 
subsequent gain of function still remains open. Our ability to answer it can be greatly 
facilitated by finding a way to map oxidation hot-spots in RNA. 
 
Detection of modification sites in RNA and DNA 
For a long time after development of Maxam-Gilbert sequencing, a method with a 
similar approach was used for mapping positions of modifications in RNA and DNA. In 
these sequencing experiments, the DNA or RNA strand is either cleaved at the modified 
nucleotides showing different susceptibility to the cleavage when compared to their 
unmodified counterparts or used as a template for the synthesis of the complement strand, 
producing truncated products because of polymerase stalling at the modification sites.20, 
145-147 Radiolabeled products of these reactions can typically be analyzed on 









Figure 1.6. Two possible ways in which oxidation of RNA can lead to a change or gain 
of regulatory function. 
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decreased intensity of a given band. However, these sequencing methods are very labor-
intensive, low-throughput, and are incapable of detection of infrequent modifications. 
Development of high-throughput or next-generation sequencing (NGS) methods has 
revolutionized the field of genomics by dramatically increasing the amount of information 
extracted from each sequencing experiment.148 Since NGS became available as a research 
tool almost 20 years ago, multiple protocols have been developed for mapping epigenetic 
marks in DNA and post-transcriptional modifications in RNA (Figure 1.7).149-154 This 
drastically improved our understanding of how structure and function of RNA and DNA 
are fine-tuned by these modifications and led to a dramatic expansion of the fields of 
epigenetics and epitranscriptomics.155-156  
Common steps required for detection of modification positions in RNA or DNA 
include fragmentation, enrichment, library preparation, and sequencing (Figure 1.8). The 
goal of fragmentation is to induce random strand breaks producing DNA or RNA fragments 
that are short enough to be sequenced. Typically, this is done by sonication in the case of 
DNA and incomplete hydrolysis in the case of RNA.157-159 The size of the fragments used 
for sequencing depends on the method. Currently the most common method for mapping 
modifications is Illumina sequencing that requires fragments shorter than 100-150 nt; 
another viable alternative is single-molecule real-time (SMRT) sequencing developed by 
Pacific Biosciences that can work on fragments longer than 20,000 nt.160-162 Multiple RNA 
species that are shorter than the threshold for the sequencing method used, such as ~22 nt-
long miRNA or ~76 nt-long tRNA, or even 5,000 nt 28S rRNA in case of SMRT 
sequencing, do not have to be cleaved. The next step after fragmentation is enrichment of 















Figure 1.8. Schematic representation of generic workflow used for mapping positions of 
modified nucleotides in DNA or RNA. 
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enrichment is achieved by using antibodies specific for a given modified nucleotide 
immobilized on solid support.154 Just as with the fragmentation, in certain cases this step 
can be omitted. Enrichment is not required when mapping positions of high-frequency 
modifications such as m5C or hm5C in DNA; however, it is absolutely crucial when trying 
to map positions of low-abundance modifications such as OG due to the fact that the 
frequency of their occurrence is comparable to the error rate of polymerases used for library 
preparation and sequencing.150, 154, 163-166 After the enrichment step, sequencing the dsDNA 
library is prepared using standard protocols that in the case of RNA sequencing includes 
reverse-transcription of the original RNA into complementary DNA (cDNA).167 
Upon sequencing of the dsDNA library, there are two major ways of defining 
positions of modification sites. The first one is a high-resolution method requiring changes 
in base-pairing capabilities of the modified nucleotide compared to the unmodified strand 
that allows determination of the positions of post-transcriptional modifications or 
epigenetic marks at single-nucleotide resolution. The shift in base-pairing properties can 
be either native (insertion of thymine opposite m6G or m2
2G)151, 168 or induced by chemical 
treatment (bisulfite sequencing of m5C or cross-linking with antibodies used in the 
enrichment step).154, 165-166, 169 In this approach, the presence of the modifications leads to 
generation of a characteristic signal when it is encountered by the polymerase. This signal 
could be either formation of truncated products, deletion of one or more bases, base 
substitution, or a combination of all signal types. Truncated products and deletions are 
formed when the polymerase is incapable of inserting one of the four standard dNTPs 
opposite the modified nucleotide that leads to either arrest of polymerization or formation 
of an extrahelical loop containing the modification site.46-47, 154, 170 Most commonly these 
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sequencing signatures are used for mapping the positions of modified nucleotides upon 
formation of their bulky adducts with antibodies.154, 169, 171-172 Products containing base 
substitutions result from different base-pairing preferences of modified and unmodified 
nucleotides leading to a specific mutation profile at the site of the modification.150-153, 168-
169, 173-174 The second approach for detecting positions of modified nucleotides is a low-
resolution method that closely resembles chromatin immunoprecipitation and sequencing 
(ChIP-seq). This method is more convenient because it does not require a specific 
sequencing signal coming from a modified nucleotide. Instead the modification sites are 
mapped at the resolution of fragmentation (~100 nt for Illumina sequencing) as spikes in 
abundance of RNA or DNA fragments coming from a specific locus.154, 175-177 
Alternatively, SMRT or nanopore sequencing can be used for mapping positions of 
nucleotide modifications in unamplified DNA (SMRT and nanopore) or RNA (only 
nanopore).161-162, 178 These methods can be used to detect modification sites in unprocessed 
DNA or RNA due to the fact that they can recognize signals other than insertion of a 
specific base by polymerase during sequencing (polymerase kinetics in case of SMRT 
sequencing and nucleotide size in case of nanopore sequencing). However, due to relatively 
high error rates of both these methods, they can only be used for locating modifications 
that occur with high frequency. 
Mapping the position of oxidation sites and OG in DNA has been accomplished 
using multiple methods such as site-specific piperidine cleavage followed by PAGE 
analysis of reaction products,42 Sanger sequencing as a single-nucleotide deletion product 
upon excision of OG with the repair enzyme and ligation of the gap in DNA179-180 or as 
unnatural hydrophobic base inserted instead of OG after repair,179, 181 and, recently, low-
23 
resolution NGS (OG-seq) using selective conversion of OG to a biotin-adduct of Sp 
(Scheme 1.2). 175, 179 Prior to the work shown here mapping of OG in RNA has only been 
attempted with the gel-based method analogous to piperidine cleavage of DNA.42 This 
topic is covered in more detail in Chapter 3 and Chapter 4. One of the goals of the research 
presented in this dissertation is to facilitate development of a method that can be used for 






































Scheme 1.2. Selective conversion of OG into biotin-adduct of Sp used for enrichment of 
OG in the sequencing library in OG-Seq method. 
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Exposure of DNA or RNA to reactive oxygen species (ROS) may result in 
modifications of DNA bases, strand breaks, or cross-links between two nucleobases or 
between nucleobases and other molecules present in the cell.1-9 Such damage can 
significantly disrupt normal cell functions such as protein synthesis and ultimately trigger 
cell apoptosis or lead to irreversible mutations in the genetic code during replication due 
to insertion of incorrect nucleotides opposite damaged DNA bases.10-13 One of the most 
abundant lesions is a two-electron oxidation product of guanine, 8-oxo-7,8-dihydroguanine 
(OG).14-15 This lesion is highly susceptible to further oxidation due to its low redox 
potential.14, 16 Oxidation of OG can yield two hydantoin lesions, 5-guanidinohydantoin 
(Gh) and spiroiminodihydantoin (Sp) in a ratio highly dependent on reaction conditions 
and sequence contexts (Scheme 2.1).17-19 OG is recognized and expelled from both DNA 
[by 8-oxoguanine glycosylase (OGG1)]20-23 and RNA [by polynucleotide phosphorylase 
(PNPase)].24-27 Both hydantoin lesions in DNA are recognized by specific DNA 
glycosylases, NEIL1 (Nei-like DNA glycosylase 1) and NEIL3 (Nei-like DNA glycosylase 














Mechanisms of repairing damaged DNA bases include two major pathways: 
Nucleotide Excision Repair (NER) (Figure 2.1, A) and Base Excision Repair (BER) 
(Figure 2.1, B).34 NER is generally triggered by the presence of bulky adducts or cross-
links that significantly perturb the helical structure of DNA.35 This repair mechanism leads 
to excision of a short single-stranded DNA fragment containing the lesion that is then 
followed by restoration of the damaged fragment based on the undamaged strand and 
ligation of the nick.35 Small lesions like OG, Gh or Sp do not induce significant changes in 
structure of the DNA helix, and thus are substrates for BER enzymes.36 The BER 
mechanism requires a set of glycosylases (each specific for a certain type of lesion) that 
can recognize the damaged base and excise it from the DNA strand creating an abasic site 
and a free damaged base as products.36 
Considering that nothing is known about the fate of Gh in RNA, the goal of the 
research presented in this chapter was the development of a system for detection and 
quantification of free Gh base produced in the process of BER based on DNA aptamers. 
The same aptamer-based sensors could then theoretically be used to detect Gh in ribo- and 
2’-deoxyribonucleotide pools. Aptamers are oligonucleotides capable of selectively and 
tightly binding to a target molecule. Free OG, Sp and Gh can serve as biomarkers of 
oxidative stress and thus can be used for cancer risk assessment or early stage detection.37-
39 Currently, specific detection of damaged nucleobases is limited to antibodies developed 
for OG.40-41 Application of aptamers, instead of antibodies, for bioanalytical measurements 
has certain advantages. Antibodies can only be produced in vivo and only for immunogenic 
and nontoxic targets, making the process quite costly, nonapplicable for some molecules 










Figure 2.1. Schematic representation of mechanism of base excision repair (A) and 
nucleotide excision repair (B) of DNA. Damage site is marked in red, nucleotides inserted 
during repair marked are in blue. 
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Selection and production of aptamers on the other hand is done in vitro, which lifts the 
limitations and makes the process significantly less expensive.42 In addition to that, like all 
other proteins, antibodies can aggregate and have limited stability as they are stable only 
in a narrow range of pH, temperature, and salt concentration with typical shelf lives of 
about one year.42 On the other hand, DNA aptamers can endure a much wider range of 
environmental conditions and their storage time is practically unlimited compared to 
proteins.42 Finally, unlike antibodies, aptamers undergo drastic changes in their secondary 
and tertiary structure upon binding to the target, which allows for building much more 
flexible biosensors43-46 and provides the potential ability to use such sensors in vivo.47-49 
The process of in vitro selection of aptamers is called Systematic Evolution of 
Ligands by EXponential enrichment (SELEX). Invention of this method was 
independently reported in 1990 by different research groups: Turek and Gold, who 
described selection of RNA aptamers for bacteriophage T4 DNA polymerase50 and 
Ellington and Szostak with the selection of RNA aptamers for several organic dyes.51 
Twelve years later, in 2002, the Breaker lab reported discovery of the first riboswitch – a 
natural RNA aptamer sensor.52-53 
Conventional procedures for in vitro selection of DNA aptamers include the 
following steps54 (Figure 2.2, A): 
1) Design the DNA library. In this case, the DNA library is a set of ssDNA with two 
constant primer regions (typically 20-30 nts in length) on 5’ and 3’ ends and a 
randomized region (with a typical length of 20-50 nts or 1012-1030 possible different 
sequences) in between. 





Figure 2.2. Schematic representation of steps in normal SELEX cycle (A) and attachment-
free SELEX cycle (B). 
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3) Incubation of the DNA library with resin containing the target followed by removal 
of strands that do not bind to the target. 
4) Separation of DNA strands that bind to the target by rinsing the resin with solution 
containing the free target molecule. 
5) PCR amplification of the enriched ssDNA library. 
6) Transformation of the amplified dsDNA library into a ssDNA library by digestion or 
separation of the complementary strand. 
Steps 3-6 are then repeated until an increase in affinity of the random DNA pool to 
the target is no longer observed. Since 1990, many new variations of the standard SELEX 
method have emerged, such as CE SELEX, tailored SELEX, or microfluidic SELEX.54-55 
However, most of these novel selection methodologies are either specific or preferable for 
development of protein-binding aptamers, while selection of aptamers for small molecules 
can still present a significant challenge.56 Immobilization of the target molecule requires 
its modification, and in the case of small molecules it can present a nontrivial synthetic 
problem or significantly alter its structure and thus interfere with the target-aptamer 
binding pattern. Attachment-free/beacon/structure-switching SELEX (Figure 2.2, B) 
allows these drawbacks to be overcome by immobilizing the ssDNA random pool instead 
of the target. In this method, during the selection, the ssDNA library is hybridized to a 
biotinylated docking-DNA strand attached to the agarose resin. Upon binding to the target 
DNA, strands should switch their structure from a complex with docking-DNA to a stem 
loop with a shorter duplex region compensating for the energy difference by interactions 
with the target.57 Although this approach requires more careful design of the primer regions 
for the DNA library and cannot be used for selection of aptamers that do not switch their 
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structure upon binding to the target, it has been successfully applied for selection of several 
aptamers and currently presents the best alternative to SELEX methods using 
immobilization of the target small molecules.57-59 
 
Materials and methods 
Synthesis of Gh free base by direct oxidation of G or OG. Oxidation of OG has 
been carried out by adding either 2 equivalents of Na2IrCl6 or 50 equivalents of K2S2O8 to 
a solution containing 1 mM OG and one of the following buffer solutions: 75 mM pH 4 
acetate buffer, 75 mM pH 4 citrate buffer, or 0.1% formic/acetic acid. Next, the reaction 
mixture containing K2S2O8 was irradiated with UV-light (350 nm) for 1 h, and the reaction 
mixture containing Na2IrCl6 was incubated for 10 min at room temperature, and then 
oxidation was quenched by addition of 6-fold excess of EDTA over Na2IrCl6. Na2IrCl6 was 
then removed by passing the reaction mixture through Dowex 1x8 anion-exchange resin 
(Sigma-Aldrich, St. Louis, MO). Oxidation of G has been carried out by irradiating the 
solution containing 1 mM G, 200 μM methylene blue, and one of the buffer solutions listed 
above for 1 h with 350 nm UV-light. Methylene blue was then removed by passing the 
reaction mixture through a NAP column packaged with G-25 Sephadex resin (GE 
Healthcare, Chicago, IL). Reaction products were analyzed by HPLC using a Hypercarb 
(150 × 4.6 mm, 5 μm) column (Thermo Fisher Scientific, Waltham, MA). The major 
product formed during the reaction in all cases had significantly lower molecular weight 
than Gh (MH+ m/z 102.07 instead of 158.07). 
Synthesis of Gh free base from dG. Oxidation of dG was carried out by following a 
literature protocol.60-61 In short, solution containing 1 mM dG, 10 μM methylene blue, and 
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75 mM pH 4 acetate buffer was irradiated for 1 h with 350 nm UV-light. Methylene blue 
was then removed by passing the reaction mixture through an NAP column packaged with 
G-25 Sephadex resin (GE Healthcare). Excess of unreacted dG was then removed by 
passing reaction mixture through Microsorb-MV 100-5 C18 (250x4.6 mm) HPLC column 
(Varian, Palo Alto, CA) and collecting the void volume containing dGh and dSp. dGh was 
then purified on Hypercarb (150 × 4.6 mm, 5 μm) HPLC column (Thermo Fisher 
Scientific) using isocratic elution with 0.1% acetic acid. Identity of dGh was then 
confirmed via electrospray ionization-mass spectrometry (ESI-MS) with MH+ m/z of 
274.10 (calc. 274.11). 
Conversion of dGh to Gh free base was then accomplished by incubating 270 nmol 
dGh in 50 μl HF/pyridine mixture at 37°C for 30 min followed by neutralizing the reaction 
mixture with Na2CO3.
62-63 Gh free base was then purified on a Hypercarb (150 × 4.6 mm, 
5 μm) HPLC column (Thermo Fisher Scientific) using isocratic elution with 0.1% acetic 
acid. Identity of dGh was then confirmed via electrospray ionization-mass spectrometry 
(ESI-MS) with MH+ m/z of 157.96 (calc. 158.07). 
Oligonucleotide synthesis. SELEX library, capture strand, and PCR primers were 
synthesized by the University of Utah core facilities following the standard solid-phase 
synthesis protocols.  
PCR amplification of the initial library. For the initial PCR amplification of the 
SELEX library, 20 pmol of the randomized DNA template was added to the freshly made 
stock solution containing 1 μM forward primer, 1 μM reverse primer, 400 μM of each 
dNTP, 1x ThermoPol reaction buffer (20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 
2mM MgSO4, 0.1% Triton X-100, pH 8.8, New England Biolabs, Ipswich, MA), and 2.5 
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U/50 μL Taq DNA polymerase (New England Biolabs) to give the final volume of 10 mL. 
Reaction mixture was divided between 100 reaction tubes (100 μL per tube) and 20 cycles 
of PCR were carried out using the following program: 15 s denaturation at 95 °C, 30 s 
annealing at 60 °C, and 45 s extension at 72 °C. The PCR products were resolved on 4% 
agarose gel, gel bands corresponding to the amplified SELEX library were excised, and 
PCR amplicons were purified using Zymoclean gel DNA recovery kit (Zymo Research, 
Irvine, CA) following protocol suggested by the manufacturer. Double-stranded SELEX 
library was converted to the single-stranded library according to the protocol described in 
the next section. All PCR reactions have been performed using C1000 Touch thermal 
cycler (BioRad, Hercules, CA). 
General SELEX protocol. Steps described below were followed for each cycle of 
SELEX. 
Immobilization: 100 pmol of ssDNA pool were incubated for 1 h with 250 µL of 
Pierce streptavidin agarose resin (Thermo Fisher Scientific) containing 10-fold excess (1 
nmol) of bound biotinylated docking-DNA. After incubation resin was consecutively 
washed 12 times with 250 µl of SELEX buffer (200 mM NaCl, 20 mM MgCl2, and 20 mM 
Tris-HCl, pH 7.4). Absorbance of Cy3 was then measured for the flow through and washes 
(Figure 2.3, A). 
Elution: Agarose resin from the previous step was incubated 3 times with 250 µL 
of Gh solution (100-10 µM) for 30 min each time, all eluates were combined together, and 
starting from round 3, 10% of the combined elute was taken for measurement of Cy3 
absorbance (Figure 2.3, B). Negative selection against 250 µl of 100 µM (dA), 2’- 












Figure 2.3. Data collected during the aptamer selection process. Example of a chart with 
the amount of DNA in flow through and 12 washes combined in pairs; red line indicates 
detection limit of 10 pmols (A). Elution profiles obtained for 3-14 rounds of Gh SELEX 
(B). BDL stands for Below Detection Limit (3.3 pmol per wash). Example of preparative 
agarose gel (C), leftmost band is a positive PCR control; 3 bands on the right are the product 
of PCR amplification. 
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OG and arginine was performed in round 6. 
PCR amplification: The combined elute was PCR amplified for 10-12 cycles using 
protocol described in the previous section. PCR products were analyzed and purified on a 
4% agarose gel as described in the previous section (Figure 2.3, C). Negative PCR no 
template control (NTC) and positive control (amplification of initial DNA library) were 
done with each PCR mixture. All reactions have been performed using C1000 Touch 
thermal cycler (BioRad). 
Strand separation: Biotin attached to the 5’-end of the PCR reverse primer allowed 
for immobilization of PCR products on streptavidin agarose resin. After PCR amplification 
250 pmol of dsDNA SELEX library dissolved in strand-separation buffer (SSB: 1 M NaCl 
and 20 mM Tris-HCl pH 7.4) were loaded on 200 µL of the Pierce streptavidin agarose 
resin (Thermo Fisher Scientific) by incubating them for 15 min at room temperature. 
Unbound DNA was then reapplied to the column and incubated for another 15 min. The 
resin was then washed 5 times with 200 µL of SSB followed by two 10 min incubations at 
the room temperature with 200 µL of 0.2 M NaOH solution. NaOH eluates containing 
ssDNA SELEX library were neutralized with 3M NaOAc. 
Cloning and sequencing. For separation and sequencing of individual aptamers 
upon completion of the selection process, TOPO TA Cloning Kit (Thermo Fisher 
Scientific) was used following the protocol suggested by the manufacturer. Prior to 
insertion into a TOPO vector supplied with the kit, dsDNA libraries from several SELEX 
rounds were PCR amplified with nonmodified primers and purified on an agarose gel as 
described in the previous section. Then to add 3’ A overhangs (“sticky ends”) required for 
plasmid insertion, 1 µL of 1 ng/µL solution of ssDNA SELEX library was combined with 
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2 µL of solution containing 10 equivalents of ATP (0.21 pmol), 1 unit of Taq polymerase, 
and 1.7x ThermoPol PCR buffer. The reaction mixture was incubated at 72 °C for 10 min. 
After that 1 µL of ddH2O, 1 µL of salt solution (1.2 M NaCl and 60 mM MgCl2), and 1 µL 
of TOPO vector stock solution (10 ng/µL) were added to the mixture, and the final reaction 
mixture was incubated for 5 min at room temperature. After each DNA library was 
individually inserted into plasmids, they were transformed into One Shot TOP10 
chemically competent E. coli cells via induced heat shock. Then bacteria cells were spread 
onto LB-agar plate containing 100 µg/ml ampicillin and 0.8 mg X-Gal.  After 20-24 h of 
incubation at 37 °C individual cultures were replanted on another set of LB-agar plates 
with ampicillin, grown for 12 h at 37 °C, transferred into 4 mL of liquid LB media and 
incubated at 37 °C for 15 h with horizontal shaking. An aliquot of each bacterial colony 
was frozen at -80 °C, and the remaining cells were used for plasmid extraction with 
PureLink Quick Plasmid Extraction Kit (Thermo Fisher Scientific) according to the 
provided instructions. All plasmids were submitted for Sanger sequencing using standard 
M13 reverse sequencing primer. 
 
Results and discussion 
Synthesis of Gh free base. The first goal of this project was to derive a method for 
synthesis of the free Gh base as a target for in vitro selection. Synthesis of Gh nucleoside 
has been previously reported by our lab with use of various single-electron and singlet 
oxygen oxidants, such as Na2IrCl6, transition metal ions with peroxide, riboflavin, and 
methylene blue.9, 64-66 At the same time, synthesis of Gh free base on a scale required for 
use in SELEX has not yet been reported. 
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The first synthetic approach was a direct oxidation of OG in a free base form. 
Synthesis was attempted with use of three different oxidants, Na2IrCl6, K2S2O8 and 
methylene blue, in phosphate, acetate, citrate and formate buffers at pH 4-5. Reaction 
mixtures were then analyzed on a Hypercarb HPLC column. Only trace amounts of Gh 
were detected by HPLC and LC-MS with K2S2O8 as the oxidant, while all reactions in 
acetate buffer with all three oxidants produced a product with absorbance peak ~204 nm 
and MH+ m/z of 102, which likely corresponds to N-acetylguanidine. At the same time, 
oxidation of OG with methylene blue in water without any buffer (pH~6.5) produced 
significant quantities of Sp free base. Acquired data suggested that one of the intermediates 
of OG to Gh oxidation or Gh itself is unstable in the form of free base. Thus, a 2-step of 
synthesis starting from 2’-deoxyguanosine was chosen as an alternative (Scheme 2.2). 
During the first step, dG was oxidized with methylene blue to form dGh that was 
characterized and purified by HPLC. The second step was treatment of purified dGh with 
HF/pyridine, which led to base elimination and decomposition of the sugar.62-63 The Gh 
free base was then purified by HPLC and characterized by UV absorbance and MS data. 
The final yield was estimated from UV absorbance at 240 nm based on the assumption that 
extinction coefficients are the same for dGh (2412 dm3 mol-1 cm-1) and Gh.65 
Aptamer selection. As previously described, the attachment-free SELEX method 
was then used for selection of aptamers for Gh. The DNA library (Figure 2.4) similar to 
the one previously described by the Stojanovic lab was used for the selection process.57 
Each strand had an N30 random region that provides up to 10
18 possible different sequences. 
The forward primer region was modified with Cy3 dye on its 5’ end. Cy3 modification 































Figure 2.4. Principle of structure-switching SELEX and sequences of DNA library, 
primers, and docking-DNA used for the SELEX. 
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SELEX 100 pmols of randomized DNA pool were PCR amplified to have a stock solution 
of the same DNA sequences that were to be used for in vitro selection. A total of 14 rounds 
of SELEX were completed according to the protocol described in the materials and 
methods section of this chapter. Concentration of a target molecule (Gh) and number of 
PCR cycles used for amplification of the strands eluted by the target in each SELEX cycle 
can be found in Table 2.1. 
It should be noted that in all of the 14 SELEX rounds performed for Gh, the amount 
of DNA pool eluted with the target solution was never above the detection limit (3 pmol). 
This can either be attributed to the low affinity of the selected DNA library to Gh, or to a 
low rate of DNA pool enrichment with aptamers having low KD values which can be caused 
by a large amount of DNA strands that can weakly bind to the target containing the 
positively charged guanidinium group without change in aptamer conformation required 
for elution. To test whether this was specific for Gh, we conducted several rounds of in 
vitro aptamer selection for dG and G free base (Table 2.2). Selection of aptamers for these 
two targets did not encounter similar problems. 
Analysis of sequencing data. The first set of sequencing data was obtained for the 
aptamer library after the 14th round of SELEX. A total of 29 sequences of sufficient quality 
were retrieved from 37 submitted plasmids. Out of these 29 sequences (Table 2.3), only 13 
had different N30 random regions with 3 sequences (C14S1, C14S2, C14S3) being 
represented 4 or more times. All 29 sequences demonstrated significant mutations in the 
antisense reverse primer (aRP) region, and only 2 sequences (34 and 36) demonstrated no 
changes in the original aRP sequence (marked in red, Table 2.3), while other sequences 




































































































































































at least one incomplete repeat of aRP region (marked in green, Table 2.3) with 3 
nucleotides missing on the 5’ end and 1-14 nt insertions in between the aRP regions. 
Problems with primer repeats sometimes arise for PCR amplification products in 
the case of poor primer design (including the possibility of substantial self-
complementarity). Although it generally results in high molecular weight smears on the 
gel, this was not the case in our situation. Alignment of N30 random regions (Figure 2.5) of 
all 13 sequences showed substantial similarities in the first 13-20 nucleotides, while the 3’ 
ends of all sequences were significantly more specific for all the strands and coincided with 
different mutation patterns in the first aRP region. This suggested that repeats of the aRP 
region are possibly caused by its hybridization with the end of the N30 region during PCR, 
and mutations in the first aRP sequence accommodate such folding (Figure 2.6, A). Strands 
with primer repeats unexpectedly emerged as a major PCR product after the 11th round of 
SELEX (Figure 2.6, B). At that point, a slight shift upwards in the position of a band on 
the agarose gel was attributed to possible insertions in the random region or gel defects. 
Thus, SELEX rounds 12-14 were performed exclusively for an elongated DNA library. 
The fact that strands with primer repeats became the almost exclusive PCR product in 
round 11 from not being observed at all in round 10 suggests that the elongated library may 
have improved binding affinity towards the selection target. Such a sudden change should 
have been preceded by sufficient accumulation of either DNA strands with similar 
randomized regions or observed mutations in the aRP primer region. Another possible 
explanation could be more efficient PCR amplification of elongated strands, although it is 

















     C14S1     AACCAGA GAGCCGACAG ATTGGAACTG AGG 
    C14S10      ACGAGA GACTCCCACG AATAAAGCAG AACG 
     C14S7   ACAACACGA GAGACTCCAG ATCTACAGCA 
    C14S12  AGGAACACGA GAGACTCCAG AAGTGCTATC         
     C14S5         AGA GGGCCTCCTC GATAGTGTTT AAACGTG 
     C14S6         AGA GAGGCTCCAA GTTTTCTGTC GAGGGTG 
    C14S4’     ACCCGAC GAGACTCCTA ACGGATGATG CAA     
     C14S4     ACCCGTA GAGACTCCTA CGACTGCTTA ACA     
     C14S2     AGGCCCG GAACCCGGGG TAACCCGTAG AGC     
     C14S3     AGGCCAG CCTGCTGTGG CATAACACCG AGA     
     C14S8   ATGGGCAAT GAGCGCATAA CAACTCCGAG A       
     C14S9    GGGAACCG GCGGACCAGG CCTCCCGATC GG      
    C14S11   AATGCCCGA GTGGTTGCCT CCTACCGAAT G       
 Consensus   ..a.cc.ga Gag.ctcc.g ..t..c..t. a...... 
 
Figure 2.5. Alignment of the randomized region of set of sequenced aptamers from round 
14 of SELEX. Nucleotides marked in blue are conserved among 50% of sequences, marked 










Figure 2.6. Origin and characteristics of strands with multiple primer repeats. (A) 
Structures obtained using Mfold software for C14S1 aptamer. Structure on the left – with 
normal primers, structure in the middle – with primers taken from sequence #15 (Figure 
2.5), structure on the right – with primers taken from sequences #13 and #14. Below the 
structures are given –ΔG values for all aptamer sequences calculated with Mfold. (B) 
Preparative agarose gels with PCR products after SELEX rounds 10 and 11. The yellow 
line indicates the band position of a normal-length PCR product in a lane with the positive 
control. 
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To test for the aforementioned similarities in sequences of N30 region or aRP 
mutation patterns between elongated and normal length libraries, an additional round of 
SELEX was performed starting with the dsDNA library from the 10th selection round. This 
round was marked 11’. Libraries from both rounds 10 and 11’ were then sequenced (Figure 
2.7), aligned and compared with the sequence set from round 14. Despite the fact that 
before round 11’ of selection, the dsDNA pool was carefully purified, elongated strands 
accounted for a significant portion of PCR product after selection (~50%). As a result, even 
after two rounds of agarose gel purification prior to vector insertion, 3 out of 22 obtained 
sequences for round 11’ had two aRP repeats (11-37, 11-38, 11-13). Two of these 
sequences had identical sequences of N30 region with C14S1 and C14S2, respectively, 
while the third had one nucleotide difference with C14S9. Also, among 31 sequences (22 
from round 11’ and 9 from round 10), three pairs of identical sequences were observed (10-
28 and 11-50, 11-32 and 11-42, 11-1 and 11-26). When aligned, N30 regions from normal 
length sequences and sequences containing primer repeats (Figure 2.8) on most occasions 
did not have much in common and form separate clusters, except several partially merged 
together groups containing 7 sequences (Figure 2.9). Another feature that all analyzed 
sequences share is high enrichment in A (>36% on average) with at least one run of 3-8 As 
in a row being present in most sequences. 
 
Conclusions 
In this chapter we have described a way to synthesize Gh free base, performed 14 
rounds of SELEX using Gh as a target molecule, and sequenced aptamer libraries after 













Figure 2.7. Aptamer sequences obtained for the DNA library after SELEX rounds 10 and 
11’. Sequences of PCR primer regions are marked in red, sequences of aRP repeats are 

















Figure 2.8. Alignment of full set of sequenced aptamers from rounds 14, 10 and 11’. Color 




















Figure 2.9. Cluster of similar normal and elongated sequences. Nucleotides marked in blue 
are conserved among 50% of sequences, marked in red – among 90%. 
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sequenced aptamers as well as enrichment of the DNA pool with the specific strands. Both 
these parameters can serve as a characteristic of successful selection of aptamers.67-68 
However, due to the fact that the overall aptamer library was highly mutated and that 
average library affinity for the selection target (Gh) remained low, it is not likely that the 
sequenced aptamers retained the structure-switching properties characteristic for the initial 
DNA library. Thus, measurement of affinity of the sequenced DNA strands for Gh would 
be more challenging and costly than initially expected. In parallel with development of 
aptamers for Gh, the same SELEX protocol was used by another member of Burrows lab 
to obtain aptamers for OG, dOG, Sp, and dSp.69 Although aptamers selected for those 
targets were not as mutated as the ones selected for Gh, they were found not to have 
sufficient selectivity for their target molecules. The most likely reason for that is that during 
the attachment-free SELEX apart from the aptamers that efficiently bind the target 
molecule strands that are efficient at switching structure without binding or weakly binding 
the target molecule are also selected. Because of that we decided not to pursue further 
studies of the aptamers selected for Gh. The only solution for this issue is using a different 
approach for aptamer selection. Potentially, conventional SELEX may be done for the 
products of guanine oxidation immobilized on the solid support. This immobilization can 
be achieved by using nucleosides or 2-deoxynucleosides modified with biotinylated 
polyethylene glycol tail attached to 3’-OH or 5’-OH, or short randomized biotinylated 
oligonucleotides containing one of the oxidized lesions. Alternatively, sol-gel SELEX can 
be attempted for the products of guanine oxidation, where target molecule is immobilized 
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REVERSE TRANSCRIPTION PAST PRODUCTS OF GUANINE OXIDATION 
IN RNA, 8-OXO-7,8-DIHYDROGUANINE, 5-GUANIDINOHYDANTOIN, 
AND SPIROIMINODIHYDANTOIN DIASTEREOMERS* 
 
Introduction 
The nucleic acids DNA and RNA are prone to oxidative damage from reactive 
oxygen species (ROS) that are formed during metabolism or induced by exogenous 
sources, such as UV radiation, ionizing radiation, or environmental toxins.1-4 Exposure to 
these damaging agents may result in modifications of nucleobases, strand breaks, or cross-
links with other molecules present in the cell.5-9 Oxidation of DNA has been an area of 
intense study for over two decades because it can lead to irreversible mutations in the 
genetic code that result in cancer and numerous genetic diseases.10-12 
Oxidative damage to RNA has received much less attention. The likely reasons for 
this include the many challenges of working with the inherently less chemically stable 
 
*Reproduced in part with permission from “Alenko, A.; Fleming, A. M.; Burrows, C. J., 
Reverse Transcription Past Products of Guanine Oxidation in RNA Leads to Insertion of 
A and C opposite 8-Oxo-7,8-dihydroguanine and A and G opposite 5-Guanidinohydantoin 
and Spiroiminodihydantoin Diastereomers. Biochemistry 2017, 56(38), 5053-5064.” 
Copyright 2017 American Chemical Society. DOI: 10.1021/acs.biochem.7b00730 
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RNA and the assumption that oxidation of RNA does not significantly disturb normal cell 
functions due to turnover of RNA molecules in the cell.13 While the latter may be true for 
lower organisms with predominantly short-lived RNA,14 the average half-life of mRNA in 
human cells is ~10 h while for the long-lived tRNA and rRNA this value can reach several 
days.15 On average mammalian cells contain at least as much RNA as DNA13, 16 and RNA 
itself is 2-25 times17-19 more susceptible to oxidation by ROS in vivo than DNA. Therefore, 
RNA oxidation can present a substantial challenge for cell survival, and multiple studies 
have linked it to development and progression of cancer and neurodegenerative diseases.20-
29 Recent work has discovered pathways of surveillance, sequestration, and, in some cases, 
repair of RNA damage.13, 30-34 
Among the nucleobases, guanine has the lowest redox potential (1.29 V vs. NHE) 
that makes it the major target for oxidizing agents.35 Thus, one of the most abundant lesions 
is a product of its 2-electron oxidation, 8-oxo-7,8-dihydroguanine (OG).36 The redox 
potential of OG is even lower than that of guanine (0.74 V vs. NHE) making these sites 
predisposed to further oxidation35 to yield two hydantoin lesions, 5-guanidinohydantoin 
(Gh) and spiroiminodihydantoin (Sp) (Scheme 3.1).37-38 OG has been found in both cellular 
DNA and RNA, while Gh and Sp have thus far been characterized only in cellular DNA 
and in RNA oligomers mimicking the tRNA anticodon loop or short single strands of 
RNA.18, 39-40 The latter lesion, Sp, exists as a pair of enantiomers (R-Sp and S-Sp) as the 
free base, which form a pair of diastereomers once attached to the chiral ribose or 2`-
deoxyribose components in nucleic acids.41 
Mapping positions of the oxidation sites in DNA has been used for achieving a 




















Scheme 3.1. Pathways of guanine oxidation. 
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products on the sequence and structural context.36, 42-46 However, methods that have been 
successfully used for finding where oxidation events occur in DNA cannot be directly 
applied to RNA.40 Techniques developed for mapping nucleotide modifications in DNA or 
RNA could be broken into 3 major categories.  
Category one includes methods that induce a strand break directly in the studied 
sequence by an enzyme or a chemical agent (e.g., Maxam-Gilbert chemistry, RNA 
digestion with specific RNases, or base excision from the DNA strand by repair enzymes) 
with further analysis of products by polyacrylamide gel electrophoresis (PAGE) or 
capillary electrophoresis (CE). We have previously tested the possibility of using simple 
cleavage of oxidized bases in RNA by hot aniline treatment and discovered that most 
products of guanine oxidation in RNA are more resistant to cleavage under standard 
conditions than the same lesions in DNA when treated with hot piperidine.40 In addition, 
RNA itself is more susceptible than DNA to position-independent backbone cleavage,47 
which results in a high background resulting in a limited practical use of chemical methods 
for locating lesion sites. 
Category two comprises mass spectroscopic techniques developed for 
characterization of post-transcriptional modifications in RNA (e.g., simple analysis of 
MS/MS fragmentation of oligonucleotides48 or more complex LC-MS/MS methods 
developed by the McCloskey laboratory49-51). Although these methods can possibly be 
highly useful for mapping guanine oxidation products, they have never been used for that 
purpose. Optimization of this type of analysis for detection of oxidized lesions could be 
quite challenging considering that oxidized lesions are likely to be more randomly 
distributed than localized post-transcriptional modifications. 
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The third category consists of primer extension assays utilizing either incorporation 
of natural (e.g., bisulfite sequencing of m5C, or SHAPE-MaP52) or unnatural bases (e.g., 
insertion of artificial nucleotides opposite m5C or O6-BnG53-56) opposite modified 
nucleotides or arrest of the polymerase activity, if it cannot efficiently insert a base opposite 
the modification site (e.g., adenosine methylation by DMS or older versions of SHAPE 
probing57-58). Currently, there are no known artificial bases that can be inserted opposite 
OG or the hydantoin lesions with the required specificity to exclusively map these sites.59 
At the same time, multiple studies have described insertion of canonical nucleobases 
opposite these lesions in DNA.60-65 The polymerases studied insert A or C opposite OG62-
63, 65 and A or G opposite Gh and Sp,60-61 with the ratio being highly dependent on the 
polymerase. Among the aforementioned papers, only one was focused on polymerase 
insertion fidelity opposite OG by RNA-dependent DNA polymerase62 called reverse 
transcriptase (RT). In that study, insertion opposite OG in a DNA (not RNA) template 
strand by HIV1 RT was interrogated finding insertion of A and C in a 14:1 ratio.62 
Thus, there are so far no conclusive reports on how reverse transcriptase enzymes 
behave when they encounter OG, Gh, or Sp in a RNA template. This chapter is focused on 
testing whether commercially available reverse transcriptase enzymes can insert canonical 
nucleobases opposite OG, Gh, or Sp when located in a RNA template. For the potential use 
of reverse transcription as a method for detection of oxidized guanine lesions, reverse 
transcription should result in either termination of polymerization at the lesion sites or 
insertion of any base other than C to allow discrimination from unoxidized G. Considering 
that several types of RNA (18S rRNA and tRNA in eukaryotes66) contain post-
transcriptional modifications, such as m1G or m22G, that also result in polymerase arrest,
67 
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the latter option would be preferable for application of this lesion sequencing approach to 
biological samples. Overall this study provides a foundation for development of a method 
for mapping OG, Gh, or Sp in RNA templates using reverse transcription to induce 
mutations that can be tracked after next-generation sequencing. 
 
Materials and methods 
Oligomer synthesis. DNA and RNA oligomers were synthesized by the core 
facilities at the University of Utah using solid-phase synthesis following standard 
protocols. The RNA templates containing OG were synthesized using the commercially 
available rOG phosphoramidite (ChemGenes, Wilmington, MA). The RNA strands were 
synthesized with a 3` dT to maximize the solid-phase synthesis yield of the modified RNA 
strands; the added dT will not impact the polymerase extension studies. All 
oligonucleotides were purified via analytical ion-exchange HPLC and dialyzed against 
ddH2O. 
Synthesis of the Sp and Gh hydantoins into the RNA strands was accomplished by 
Aaron Fleming. This was achieved utilizing the RNA strand with rOG incorporated via its 
phosphoramidite at the site of modification. Synthesis of Gh was conducted by dissolving 
1 nmol of rOG-containing RNA into 50 µL of ddH2O. The sample was placed on ice for 
10 min followed by a bolus addition of 12 equivalents of Na2IrCl6, and the reaction was 
allowed to progress for 30 min. The rGh-containing strands were purified from the reaction 
mixture by ion-exchange HPLC on a DNAPac PA100 column (250 x 4.6 mm). The HPLC 
mobile phases consisted of A = 9:1 ddH2O:MeCN and B = 1.5 M NaOAc (pH 7.0) in 9:1 
ddH2O:MeCN while running a linear gradient from 25% B to 100% B over 30 min with a 
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flow rate of 1 mL/min while monitoring the absorbance at 260 nm. The RNA strands 
containing diastereomers of rGh were purified and studied as a mixture because the epimers 
readily interconvert.68 The purified strands were dialyzed against ddH2O for 24 h while 
changing the ddH2O every 6 h to remove the purification salts. The rSp-containing strands 
were synthesized by placing 1 nmol of purified rOG-containing RNA into 50 µL of 20 mM 
NaPi (pH 7.4) buffer with 100 mM NaCl at 22 °C followed by a bolus addition of 12 
equivalents of Na2IrCl6. The reaction was allowed to progress for 30 min followed by 
workup via the same method outlined for the rGh-containing RNA strands. The 
diastereomers of rSp were individually purified for the polymerase studies. The absolute 
configurations for the Sp diastereomers have been determined in DNA strands and 
nucleosides but not in RNA strands or nucleosides41; therefore, we validated the absolute 
configurations for the Sp diastereomers in RNA strands and nucleosides to find identical 
results between the two polymers (Figure 3.1). The purity of the hydantoins in the RNA 
oligomers studied was determined by ion-exchange HPLC (Figure 3.2) and the product 
identities were identified by ESI-MS (OG-1 calcd = 6608.0, expt = 6608.1; Gh-1 calcd = 
6598.0, expt = 6598.5; S-Sp-1 calcd = 6624.0, expt = 6624.8; R-Sp-1 calcd = 6624.0, expt 
= 6624.5). 
Confirmation of the absolute configurations for the rSp diastereomers in a single-
stranded RNA. Previously our laboratory determined the absolute configurations for the Sp 
diastereomers in short DNA oligomers and 2`-deoxyribonucleosides.69  Our work noted 
that the elution order of the dSp diastereomers changed when going from analysis in a 
short, single strand of DNA analyzed by ion-exchange HPLC vs. dSp in the nucleoside 

















































































































Figure 3.2 . Example ion-exchange HPLC traces to demonstrate the purity of the Gh-, (S)-
Sp, and (R)-Sp-containing RNA strands. 
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order switching phenomenon occurs in short RNA strands.  Confirmation of the absolute 
configurations for the rSp diastereomers in the RNA templates studied was achieved as 
follows.  First, the RNA strands were purified to contain only one rSp diastereomer using 
a Dionex DNAPac PA100 (250 x 4.6 mm) ion-exchange HPLC column following a method 
previously described by our laboratory for dSp in a DNA strand (Figure 3.1 A).69  Next, 
the purified strands were digested to nucleosides using nuclease P1, snake venom 
phosphodiesterase, and calf intestinal phosphatase following a method previously 
described by our laboratory.70  The nucleosides were then analyzed on a Hypercarb HPLC 
(150 x 4.6 mm, 5 µm; Thermo Scientific) column to verify the elution order of the 
diastereomers switched when compared to the ion-exchange HPLC column (Figure 3.1 B). 
Lastly, to confirm the absolute configurations, the individual rSp diastereomeric 
nucleosides were HPLC purified and then analyzed by electronic circular dichroism (ECD) 
spectroscopy.  The ECD spectra obtained for each rSp diastereomer were identical to those 
previously obtained for the dSp diastereomers (Figure 3.1 C).69  Finally, this confirms that 
in the RNA templates studied, the first eluting strand has the S diastereomer of Sp and the 
second eluting strand has the R diastereomer of Sp. Characterization of rSp diastereomers 
has been accomplished by Aaron Fleming. 
Labeling of the DNA primer. To monitor progression of primer extension by reverse 
transcriptases via PAGE, the DNA primer was 5’ end-labeled with 32P following a 
procedure adopted from the literature71 using T4 polynucleotide kinase (New England 
Biolabs, Ipswich, MA.) and [γ-32P] ATP (PerkinElmer, Waltham, MA.).  
Polymerase nucleotide insertion and extension efficiency assays. The following 
enzymes were used: SuperScript III (200 U/µL, Invitrogen, Carlsbad, CA), AMV RT (25 
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U/µL, New England Biolabs, Ipswich, MA.), MMLV RT (200 U/µL, New England 
Biolabs, Ipswich, MA.), ProtoScript II (200 U/µL, New England Biolabs, Ipswich, MA.), 
and Omniscript (4 U/µL, Qiagen, Hilden, Germany). Before all primer extension assays, 
samples were annealed by heating 10-14 µL of an aqueous solution containing 0.44 pmol 
(22 nM in a final volume of 20 µL) of RNA template and 0.4 pmol (20 nM in 20 µL) DNA 
primer including ~30,000 cpm of 32P-labeled strand to 95 °C for 5 min, then incubating 
them at 55 °C for another 5 min followed by cooling at 15 °C for 10 min. Upon completion 
of annealing, stock solutions of reaction buffer (50 mM Tris-HCl, 75 mM KCl (75 mM 
KAc for AMV RT), 3 mM MgCl2 (8 mM MgAc2 for AMV RT), pH 8.3 in 20 µL, 1x 
commercial reaction buffer for Omniscript), DTT (10 mM in 20 µL and the commercially 
defined concentration of DTT in the buffer for Omniscript), dNTPs were added to the 
reaction mixture to bring the volume to 18 µL. Then 2 µL of stock solution containing one 
of the reverse transcriptases in 50% glycerol was added to give a final volume of 20 µL 
(final concentrations of dNTPs and enzymes are provided in the next paragraph). Reaction 
mixtures were incubated for 30 min at 37 °C, and then to quench the reaction, the mixture 
was diluted with an equal volume of 2x gel loading buffer (8 M urea, 0.01% xylene cyanol, 
0.01% bromphenol blue, x1 TBE buffer) and heated to 95 °C for 10 min. About 15 µL of 
the resulting solution were analyzed via 20% denaturing PAGE. Gels were stored with a 
storage phosphor screen for 12-18 h that was then scanned using a phosphoimager. The 
resulting images were analyzed using ImageJ2 software.72-73 For alignment of the gel lane 
pixel density plots, they were rescaled along the y-axis to normalize intensities and 
translated along the x-axis without rescaling to align the peaks corresponding to the 
unextended primer. 
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Final concentrations of enzymes and triphosphates for polymerase nucleotide 
insertion studies were as follows: for templates containing OG or G – 50 µM dATP, dCTP, 
dGTP, or dTTP, 3U SuperScript III, 0.4 U AMV RT, 2 U MMLV RT, 5U ProtoScript II, 
0.3 U Omniscript in 20 µL; for Gh-1 template – 100 µM individual dNTPs, 4U SuperScript 
III in 20 µL; for S-Sp-1 template - 200 µM individual dNTPs, 40U SuperScript III in 20 
µL; for R-Sp-1 template - 200 µM individual dNTPs, 20U SuperScript III in 20 µL. Final 
concentrations for full extension efficiency study were 100U of SuperScript III in 20 µL 
and 500 or 200 µM of each dNTP (dATP, dCTP, dGTP, and dTTP). Final concentrations 
for comparing extension efficiency past OG-A and OG-C were 6U SuperScript III in 20 
µL and 100 µM dATP for lanes 1 (A), 2 (AT), 7 (AC), and 8 (ACT), 200 µM dATP for 
lane 5 (2A), 100 µM dCTP for lanes 3 (C), 4 (CT), 7 (AC), and 8 (ACT), 200 µM dCTP 
for lane 6 (2C), and 100 µM dTTP for lanes 2 (AT), 4 (CT), and 8 (ACT). Final 
concentrations for comparing extension efficiency with Gh-1 template were 8U 
SuperScript III in 20 µL and 200 µM dATP for lanes 1 (A), 2 (AT), 7 (AG), and 8 (AGT), 
400 µM dATP for lane 5 (2A), 200 µM dGTP for lanes 3 (G), 4 (GT), 7 (AG), and 8 (AGT), 
400 µM dGTP for lane 6 (2G), and 200 µM dTTP for lanes 2 (AT), 4 (GT), and 8 (AGT). 
Final enzyme concentrations for reactions using S-Sp-1 and R-Sp-1 templates were 80U 
and 40U SuperScript III in 20 µL correspondingly; concentrations of triphosphates were 
the same as described for the Gh-1 template. 
Steady-state kinetics. A procedure analogous to that described in the previous 
section was used with the following changes. Instead of 30,000 cpm of 32P-labeled strand, 
100,000 cpm was added. After annealing, only reaction buffer and DTT stock solutions 
were added, and then the samples were preincubated for 1 min at 37 °C, followed by 
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addition of 2 µL of SuperScript III stock solution to give 1U (OG), 4U (Gh), 10U (R-Sp), 
or 20U (S-Sp) in 20 µL followed by preincubation for another 1 min at 37 °C and then 
addition of 2 µL of a stock solution of dATP, dCTP, or dGTP of varied concentrations to 
initiate the reaction. Next, 5-µL aliquots were taken in regular time intervals for the first 2-
2.5 min of reaction, rapidly mixed into an equal volume of the loading buffer and heated 
to 95 °C for 10 min. The diluted stock solutions of triphosphates and enzymes were 
prepared fresh and used the same day. Samples were analyzed on a denaturing PAGE gel 
the same way as described above. Intensities of the bands corresponding to the unextended 
primer (P) and the primer extended by one base (P+1) were quantified using ImageJ2 
software72-73 and converted into the concentration of P+1 strand using eq 1,61, 74 where CP+1 
is the concentration of P+1 strand, Ct is the total concentration of the radiolabeled primer, 
and IP and IP+1 are intensities of P and P+1 bands on the gel. No significant accumulation 
of higher-order bands was observed. Initial reaction velocities were extracted from fitting 
the data in coordinates of CP+1 (nM) vs. time (min) to a linear regression curve as a slope 
of the fitted line (Figure 3.3). Each experiment was repeated at least 3 times. Conversion 
of Vmax to kcat was achieved using specific activity and the molecular weight of SuperScript 
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Results and discussion 
Reverse transcriptases. Reverse transcriptases are polymerase type enzymes that 


















Figure 3.3. Example of data processing for determining initial nucleotide 
incorporation rates. 
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this type have been discovered in prokaryotes and yeast,75-76 the majority of them have 
retroviral origins. Most commercially available reverse transcriptase enzymes originate 
either from Avian Myeloblastosis Virus (AMV) RT or Moloney Murine Leukemia Virus 
(MMLV) RT. The primary purpose of reverse transcription in contemporary research is 
sequencing and quantification of mRNA via RT-PCR and RT-qPCR. Engineered versions 
of these enzymes have been created by multiple vendors to improve their stability, 
sensitivity, and reverse transcription yield (Table 3.1).77-78 In the current study, we screened 
insertion profiles of 5 RT enzymes (underlined in Table 3.1) opposite OG and G in a RNA 
template. Because similar insertion profiles have been observed for all reverse 
transcriptases used, only one of them, SuperScript III, was picked for further experiments. 
SuperScript III was chosen over other enzymes due to it being one of the polymerases of 
choice for next-generation sequencing of RNA.58, 77-80 
Polymerase nucleotide insertion studies. To study the behavior of RT enzymes 
encountering products of guanine oxidation in RNA, we designed two RNA-DNA hybrid 
duplexes (Figure 3.4). Both of them employ the same DNA primer and are suited for 
studying reverse transcription under standing start conditions with the only difference 
between the two being two nucleotides on the 5’ end following guanine or its oxidation 
products. To perform an initial evaluation of reverse transcription as a way of detecting 
oxidized lesions, we studied insertion profiles opposite G and OG in both RNA templates 
for 5 RT enzymes: SuperScript III, AMV RT, MMLV RT, Omniscript, and ProtoScript II. 
To do so, we ran reverse transcription reaction with A, G, C, or T triphosphates in separate 
tubes for a fixed amount of time and resolved reaction products on a polyacrylamide gel. 


























Figure 3.4. Studied RNA-DNA hybrid duplexes. 
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1 nmol dTTP in 50 µL in 10 min at 37 ºC using poly(rA)18 • poly(dT)12-18 duplex and 
500 µM dTTP), their activities are standardized under different conditions (0.1-0.4 mM 
primer-template duplex, 3-6 mM MgCl2, 40-75 mM KCl, 1-10 mM DTT, 0-0.1 mg/mL 
BSA; no data are available on Omniscript). Additionally, there are slight variations in the 
reaction buffers supplied with AMV and the other enzymes that were used for the reactions 
(75 mM KOAc instead of 75 mM KCl and 8mM MgOAc2 instead of 3 mM MgCl2; no data 
are available on Omniscript reaction buffer composition). Thus, we found it necessary to 
individually adjust the concentration of each enzyme to achieve ~50% insertion of dCTP 
(50 µM) opposite OG in the OG-1 strand. Results of the interrogation of nucleotide 
insertion profile of the reverse transcriptases studied are presented in Figure 3.5, Figure 
3.6, and in Table 3.2. On the gels, the lowest band corresponds to the unextended primer 
(P) and all bands above it correspond to a primer extended by 1 (P+1), 2 (P+2), or 3 (P+3) 
nucleotides.  
Although some reverse transcriptases showed a preference for one sequence 
context over another (e.g., SuperScript III gave more primer extension product for the OG-
1 template than for the OG-2 template), all examined enzymes demonstrated matching 
nucleotide insertion profiles inserting C or A opposite OG and C or T opposite G when 
only one of the dNTPs was present. Considering that the assayed reverse transcriptases 
demonstrated similar patterns of nucleotide insertion for both RNA templates, we limited 
further studies to using only SuperScript III and template number 1 (Figure 3.4). Before 
examining which nucleotides are inserted opposite Gh and diastereomers of Sp, we again 
made adjustments to concentrations of the triphosphates and the enzyme to achieve similar 









Figure 3.5. Nucleotide insertion profiles opposite G or OG in the templates. Insertion of 
A, G, C, or T in the reaction mixture with only one of the dNTPs present by SuperScript 











Figure 3.6 . Insertion profiles opposite G and 8-OG in the templates for ProtoScript II (A), 







Table 3.2. Results of nucleotide insertion assays for AMV RT, MMLV RT, and 
ProtoScript II RT. 
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templates containing products of guanine oxidation decreased in the following order: 
OG>Gh>>R-Sp>S-Sp. All three hydantoin lesions showed similar base pairing preferences 
leading to insertion of A or G (Figure 3.7). Insertion of A or G opposite Gh, S-Sp, and R-
Sp when only one of the triphosphates was present was similar to insertion of A or C 
opposite OG, in perfect agreement with what was previously reported for insertion opposite 
these lesions in DNA.60-63, 65 These results show that reverse transcriptases are capable of 
inserting canonical A, G, or C bases opposite OG, Gh, S-Sp, and R-Sp in an RNA template.  
Steady-state kinetics. To examine SuperScript III behavior when it encounters 
oxidized lesions in more detail, we studied the kinetics of insertion of A or C opposite OG 
and A or G opposite Gh, S-Sp, or R-Sp in the template RNA strand. Additionally, insertion 
of C opposite G in the template was studied for a comparison that served as a control for 
SuperScript III kinetics when encountering canonical bases. Initial velocities of first-base 
insertions were derived in units of nM/min and plotted against concentration of 
triphosphate used in each case. The data were then fitted to the Michaelis-Menten equation 
(eq 2) to determine the steady-state kinetics parameters Vmax and KM. Vmax was then divided 
by the total enzyme concentration to calculate kcat according to the eq 3. Michaelis-Menten 
curves and calculated kinetics parameters are shown on Figure 3.8, Figure 3.9, and Table 


















Figure 3.7. Nucleotide insertion assays for Gh and Sp. (A) Insertion of A, G, C, or T in the 
reaction mixture with only one of the dNTPs present by SuperScript III reverse 
transcriptase for Gh-1, S-Sp-1, and R-Sp-1 templates. (B) Structures of the base pairs 





























Figure 3.9. Michaelis-Menten plots for insertion of A or G opposite S-Sp (A), A or G 

















Table 3.3. Steady-state kinetic parameters.  
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Three main parameters derived from the Michaelis-Menten curve are kcat, KM, and 
their ratio kcat/KM. The catalytic rate constant or turnover number kcat indicates the 
maximum number of reactions a single enzyme can catalyze per unit of time. In the case 
of reverse transcription, it is a combination of the rate of catalysis (condensation between 
3’ end of the primer strand and a triphosphate being inserted opposite a studied base) and 
the rate of dissociation between the primer-template complex and the enzyme after the 
primer extension. 
For polymerases, kcat is normally defined by the rate of the slower dissociation 
step;62-64, 83-84 thus, it was not surprising that we observed very close values with 
overlapping confidence intervals for formation of OG-A (2.5 ± 0.1 min-1), OG-C (2.4 ± 0.2 
min-1), and G-C (2.7 ± 0.2 min-1) base pairs. Similarities between turnover numbers for 
incorporation of a base opposite G and OG have been previously reported for translesion 
DNA polymerase η and HIV-1 RT by the Guengerich laboratory.62, 64 Unlike that of OG, 
the rate of phosphodiester bond formation apparently was affected by the presence of 
hydantoin lesions in the template strong enough to result in lower kcat values for Gh-A (0.69 
± 0.08 min-1), Gh-G (0.55 ± 0.03 min-1), S-Sp-A (0.071 ± 0.006 min-1), S-Sp-G (0.056 ± 
0.002 min-1), R-Sp-A (0.196 ± 0.003 min-1), and R-Sp-G (0.12 ± 0.01 min-1) base pairs. 
The kcat values for templates containing different products of guanine oxidation follow the 
same rule as reactivities determined for the nucleotide insertion assays: OG>Gh>R-Sp>S-
Sp (Figure 3.5 and Table 3.2). Interestingly, in all cases, the kcat values for insertion of A 
were higher than for the insertion of C.  
For polymerases, the Michaelis-Menten constant KM indicates how well an enzyme 
utilizes the substrate, but it cannot be directly linked to the dNTP dissociation constant.64, 
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84 The calculated KM values for insertion of C opposite G were more than 3 orders of 
magnitude higher than for the oxidized lesions showing that SuperScript III has a strong 
preference for this conventional Watson-Crick base pair. When we compared KM values 
for insertion of A, C, or G opposite each product of guanine oxidation, in the case of OG 
we observed a significantly higher (2-fold) value for the OG-C base pair than for the OG-
A base pair, while for Gh, S-Sp, and R-Sp, substantially higher values for Gh-A (6-fold), 
S-Sp-A (3-fold), and R-Sp-A (5-fold) were observed compared to those of the base pairs 
with G. From the kcat and KM values measured, we could calculate their ratio, kcat/KM, the 
catalytic efficiency of the enzyme that is proportional to a rate of dNTP insertion when the 
concentration of dNTP approaches 0. Catalytic efficiency is commonly used to determine 
enzyme preference for one dNTP over another as a substrate. Based on the determined 
kcat/KM values, SuperScript III has a 2.5-fold preference for inserting A over C opposite 
OG, a 6-fold preference for inserting G over A opposite Gh, a 2.4-fold preference for 
inserting G over A opposite S-Sp, and a 3-fold preference for inserting G over A opposite 
R-Sp. 
Having the sequencing for oxidative damage to G in RNA as an ultimate goal, we 
used the steady-state kinetic parameters to estimate the ratio of nucleotides inserted 
opposite each studied base. This information would allow us to know if during cDNA 
synthesis SuperScript III would provide characteristic mutations that could be analyzed in 
order to locate sites of G oxidation. The results are shown in Table 3.3. The estimated 
insertion ratios were: for OG 1:1.4 C to A; for Gh 1:1.5 A to G; for both Sp diastereomers 
1:1.3 A to G. Overall these data suggest that OG and the hydantoin lesions in RNA can be 
detected by sequencing cDNA created upon reverse transcription of RNA containing these 
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products of guanine oxidation. While the three hydantoin lesions Gh, S-Sp, and R-Sp are 
likely not to be distinguishable by this method due to the similar sequencing signals 
observed in these studies, they should be easily separable from G and OG. Furthermore, 
knowing that a hydantoin is present at a given site in RNA would be a significant 
advancement in our knowledge of oxidative modification of RNA in cell. For the purpose 
of sequencing, a higher fraction of A insertion than C opposite OG is preferable because it 
allows an easier differentiation between unoxidized G and OG that is essential to increase 
the method sensitivity. Overall, based on the determined kinetic parameters, 3 different 
sequencing signals are expected in which G provides ~100% C insertion, OG yields A 
insertion at the modified site with ~60% efficiency, and the hydantoins yield insertion of a 
mixture of A and G with a modest preference for G. 
Extension efficiency studies. After discovering which bases are inserted opposite 
OG, Gh, S-Sp, and R-Sp, we wanted to investigate whether the extension efficiency is 
affected by what nucleotide is inserted opposite the lesions. To test this, we performed 
primer extension assays using different combinations of dATP, dTTP, and dCTP (for OG) 
or dGTP (for the hydantoins). The reactions were conducted at twice higher concentrations 
of enzyme (6 U for OG, 8 U for Gh, 80 U for S-Sp, and 40 U for R-Sp in 20 µL) and 
increased concentrations of the triphosphates (100-200 µM for OG and 200-400 µM for 
Gh and Sp), compared to the nucleotide insertion studies; the reason for these changes was 
to drive the reaction closer to complete base insertion opposite the lesion site and be able 
to analyze products of primer extension past the site. The results of these studies are 
presented in Figure 3.10, Table 3.4, and Figure 3.11. On the gels, lanes 2 (AT) and 4 (CT 





Figure 3.10. Efficiency of extension past different base pairs. (A-D) Polyacrylamide gels 
showing results of primer extension in the presence of one (lanes 1, 3, 5, and 6), two (lanes 
2, 4, and 7), or three (lane 8) different triphosphates aimed at comparing bypass 
efficiencies for base pairs between OG, Gh, S-Sp, and R-Sp and A, C or G. Samples in 
lanes 5 and 6 marked 2N contained doubled concentration of corresponding dNTP 
compared to those in lanes 1 and 3. (E) Aligned gel lane plots showing separation between 








Table 3.4. Efficiency of extension past different base pairs formed by OG (A), Gh (B), S-
Sp (C), and R-Sp (D) (analysis of gels from Figure 3.10). Tables to the left show fractions 
of all bands within one lane, tables to the left show fractions of all bands within one lane 

















Figure 3.11 . Comparison of extension efficiency by Omniscript RT past OG-A and OG-
C base pairs for the OG-1 template. 
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inserted opposite an oxidized lesion (A and G or C) and dTTP sufficient for full extension 
of the primer, respectively. Thus, these studies can be used to discover which of the base 
pairs is more disruptive to the duplex structure and causes more polymerase inhibition. 
Lanes 1 (A) and 3 (C or G) serve as a control of the basal level of insertion of the first base 
under the same reaction conditions. Lane 8 (ACT or AGT) corresponds to reaction 
mixtures containing both triphosphates of the nucleotides that can be inserted opposite OG, 
Gh, or Sp and dTTP shows how the efficiency of extension past the studied base is affected 
by the presence of both possible base pairs in the ratio at which they are inserted by reverse 
transcriptase. Lane 7 serves as a control of the extent to which the first base is inserted 
under the same conditions. Lanes 5 and 6 serve as additional controls for insertion levels 
of the first base under twice higher concentrations of triphosphates corresponding to a sum 
of concentrations of dATP and dCTP or dGTP for lane 7. If the efficiency of insertion of 
the first base in lane 7 is higher than in lanes 1 and 3, lanes 5 and 6 should show whether 
it is achievable simply by matching total dNTP concentrations. 
From the gels, it is evident that there is almost no difference in the level of 
polymerase blocking by the OG-A and OG-C base pairs (Figure 3.10 A). Although the 
presence of an OG-C base pair results in slightly more efficient insertion of the first T (CT 
lane) directly following C, insertion of the second T is less efficient than in presence of an 
OG-A base pair (AT lane) leading to a similar amount of full extension product for both 
base pairs. Expectedly, a mixture of OG-A and OG-C base pairs leads to a very similar 
level of polymerase blocking (lane 8). Thus, there is practically no difference between OG-
A and OG-C base pairs when it comes to how efficiently reverse transcription proceeds 
after them, meaning that the ratio at which they are inserted opposite OG should match the 
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A:C ratio in a full-length cDNA. 
For the template containing Gh, the presence of a Gh-G base pair (GT lane) leads 
to significantly more efficient insertion of the first T than of the Gh-A base pair, but the 
polymerase struggles to insert the next base (Figure 3.10 B and Table 3.4 B). In the case 
of a Gh-A base pair (AT lane), the most polymerase blockage is observed right after 
insertion of A. The presence of both dATP and dGTP in the reaction mixture (AGT lane) 
leads to polymerase arrest primarily after insertion of the T directly following the position 
of the Gh-N base pair. This hints at predominant insertion of G that aligns with the kinetic 
data for A and G insertion. Overall, insertion of G and A led to formation of comparable 
amounts of the fully extended primer, indicating that extension efficiency should not affect 
the A:G ratio in the fully extended cDNA.  
Templates with R-Sp or S-Sp showed similar behavior with more efficient bypass 
of Sp-A base pairs in the AT lane than Sp-G base pairs in the GT lane (Figure 3.10 C, D 
and Table 3.4 C, D). An intermediate amount of polymerase blockage was observed for 
the case when both dATP and dGTP were present (AGT lane) for both Sp diastereomers, 
indicating that both bases are inserted in this case. Due to a lower amount of polymerase 
blockage caused by the Sp-A bypass, it is likely that the fraction of this base pair in the 
fully extended cDNA would be higher than the ~45% estimate from the insertion kinetic 
studies.  
There are two other noteworthy details about the gels in Figure 3.10. First, in all 
cases apart from the extension product of the expected length (P+3 for lanes 2, 4, and 8; 
P+1 for lanes 1, 3, 5, 6, and 7), a product overextended by one base was also observed. 
This is especially prominent in the case of the OG-1 template and can be attributed to strong 
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template-independent polymerase activity of reverse transcriptase enzymes.85-86 Second, 
the P+1 and P+3 bands are significantly broader in lanes 7 and 8 when both triphosphates 
are present. This is especially prominent for the Sp diastereomers and is caused by the 
dependence of electrophoretic mobility on nucleotide composition [C(fastest)>A>T>G].65, 
87 Thus, insertion of a mixture of two nucleotides opposite OG, Gh, or Sp leads to a mixture 
of two cDNA strands with slightly different electrophoretic mobilities resulting in either 
broadened or split bands on the polyacrylamide gel. This can be used to obtain a rough 
estimate of the composition of bases inserted opposite each studied lesion when both 
dNTPs are present. To do so, we generated pixel density plots for lanes 1, 3, 5, 6, and 7 
and aligned them to match the position of the peak corresponding to the primer (P) (Figure 
3.10 E). It is possible to characterize insertion of A and C or G only qualitatively from 
these data due to the presence of the overextended peak P+2 and overlap between peaks 
corresponding to insertion of different bases. What could be said based on these plots is 
that A is predominantly inserted opposite OG, G is predominantly inserted opposite Gh, an 
almost 1:1 ratio of A:G is inserted opposite S-Sp, and a slightly larger fraction of G than A 
is inserted opposite the R-Sp isomer. Considering that Sp does not form stable base pairs 
with any natural nucleotides,61 insertion of comparable amounts of A and G opposite the 
hydantoin most likely can be attributed to fitting in the SuperScript III active site due to a 
similar size and minor groove binding pattern of Sp to C or T,88-90 rather than to efficient 
hydrogen-bonding with A or G. The ratio of A to C incorporated opposite OG by the 
polymerase can significantly deviate from the one calculated based on kinetic parameters 
in the presence of multiple triphosphates.64 Thus, we tested whether this was true for 












Figure 3.12. Estimation of nucleotide insertion ratio by PAGE opposite 8-OG (A), Gh (B), 
S-Sp (C), or R-Sp (D) in the template. Brightness for the lanes marked with * was adjusted 
separately from the rest of the gel. Primer extension was performed as described in 
materials and methods using indicated amount of SuperScript III reverse transcriptase in 
20 µL. On the gels lanes 1-3 correspond to reactions containing 200 µM dATP, lanes 8-10 
– 200 µM dCTP or dGTP, lanes 11-13 – 500 µM mixture of dATP and dCTP or dGTP, 







Figure 3.13. Estimation of nucleotide insertion ratio by PAGE, gel lane plots. (A) 
Combined plots of all lanes showing alignment; (B) Plots of lanes done in triplicate (1-3, 
8-10, and 11-13) showing reproducibility of relative peak positions; (C) Plots of P+1 peak 
showing ratios of insertion of A and C or G at different dNTPs concentrations (only one 
representative peak is shown for the samples done in triplicate). 
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characterization of the insertion rate was possible we attempted to adjust concentrations to 
achieve an ~1:1 insertion ratio and compared it to the one expected from the reaction rates 
calculated at those concentrations (Table 3.5). In all four cases, insertion of a larger fraction 
of A over C or G than expected from the kcat and KM was observed. Expected insertion 
ratios were within one standard deviation (SD) for Gh and R-Sp, two SDs for S-Sp, and 4 
SDs for OG. Additionally, insertion ratios at 500 µM concentration of competing 
triphosphates were studied showing ~1:1 insertion of A and G opposite both Sp 
diastereomers, almost exclusive insertion of A opposite OG, and predominant insertion of 
G opposite Gh (Figures 3.12 and 3.13).  
The other question that we wanted to ask was how efficiently reverse transcriptases 
can fully extend the primer when a G oxidation product is located in the template strand. 
For this purpose, we ran RT reactions with RNA templates containing OG, Gh, the Sp 
diastereomers, or G, using the latter study as a control, under conditions close to those 
recommended for SuperScript III by the manufacturer of the polymerase (500 µM and 200 
µM mixture of all four dNTPs and 100 U of enzyme in 20 µL). Products of the extension 
reactions were resolved on polyacrylamide gels (Figure 3.14). As expected, RNA templates 
containing G gave the largest amount of the full extension product (~80% with 500 µM 
dNTPs), while the presence of OG, Gh, or R-Sp in the RNA template resulted in a 
decreased amount of the fully extended primer (~60%), and the S-Sp-1 template gave the 
smallest amount of the full extension product (~40%). Although all tested RNA templates 
gave the full extension product, it is apparent that OG, Gh, and Sp cause some level of 
polymerase inhibition even after the primer is extended past their position, most likely due 
















Table 3.5. Comparison of insertion ratios derived from kinetics and gel-mobility assay. 
“Calculated insertion ratio” – insertion ratio calculated from steady-state kinetic 
parameters for the given concentrations of dNTPs. “RSD” – relative standard deviation, 
“SD” – standard deviation, “# of SD to 1:1” – how many standard deviation intervals it 









Figure 3.14. Efficiency of complete primer extension. (A) Polyacrylamide gel showing 
the efficiency of synthesis of full-length cDNA based on the templates containing G, OG, 
Gh, S-Sp, or R-Sp at two different concentrations of the dNTP mixture. (B) Aligned gel 
lane plots for different templates for reaction mixtures containing 500 and 200 µM of each 
dNTP. 
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with the flanking bases.91-92 Interestingly, the highest level of inhibition was caused by S-
Sp which was also found to be the most blocking in the polymerase nucleotide insertion 
studies (Figure 3.5). Analysis similar to the one presented in Figure 3.10 E was performed 
on fully extended primers (Figure 3.14 B). Results for OG-1 (predominant insertion of A) 
and Gh-1 (predominant insertion of G) templates were comparable to those obtained for 
the insertion ratios of the first nucleotides in the presence of multiple dNTPs (Figures 3.10, 
3.12, and 3.13). For both diastereomers of Sp, we observed a minor increase in the fraction 
of fully extended primer containing A inserted opposite Sp compared to the primer 
extended by just one nucleotide. This led to full-length cDNA containing an ~1:1 ratio of 
A to G for the R-Sp-1 template and a larger fraction of A for the S-Sp template. Most likely 
this result was caused by a higher efficiency of bypassing the Sp-A base pair than the Sp-
G base pair by the SuperScript III, as highlighted above. 
 
Conclusions 
In this study, we investigated the behavior of reverse transcriptases when they 
encounter products of guanine oxidation, OG, Gh, S-Sp, and R-Sp, in an RNA template 
under standing start conditions. Insertion of A or C opposite OG and A or G opposite the 
hydantoin lesions was observed that correlated with the previous reports for DNA 
containing these bases.37, 61, 64 We also reported steady-state kinetic parameters for single 
nucleotide insertion opposite the studied lesions in the 5’-AXC-3’ sequence context by the 
SuperScript III reverse transcriptase. Results of this assay indicated a preference for 
insertion of A opposite OG and G opposite the Gh and Sp diastereomers. We discovered 
that all these lesions can be bypassed by the SuperScript III under the standard conditions 
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used for RNA sequencing with sufficient efficiency to yield full-length cDNAs containing 
A or C inserted opposite OG with predominance of A, A or G inserted opposite Gh with 
predominance of G, A or G inserted opposite S-Sp with minor preference for A, and an 
equal amount of A or G inserted opposite R-Sp. These data indicate that mapping positions 
of OG, Gh, and Sp in RNA is potentially achievable with the use of reverse transcription 
to induce characteristic mutations upon cDNA synthesis. Sequencing of the cDNA strand 
should allow separate detection of unoxidized G as a nonmutagenic C, OG as a C to A 
mutation (G to T in the complementary stand), Gh as a C to G mutation (G to C in the 
complementary stand), and the Sp diastereomers as an ~1:1 mixture of C to A and C to G 
mutations (G to T and G to C in the complementary strand). Post-transcriptional 
modifications of G and I that disrupt their base pairing preference for C (m1G, m2G, m22G, 
and m1I) give different sequencing signals (preferential insertion of T93-94) and could be 
removed with dealkylating enzymes.67, 95 Therefore, they should not interfere with the 
reverse transcription results for the oxidized guanine lesions. Relatively efficient bypass of 
all lesions studied also permits amplification of cDNA via PCR (RT-PCR) which allows 
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SEQUENCING OF RNA FOR PRODUCTS OF GUANINE OXIDATION 
 
Introduction 
In Chapter 3 we studied which nucleotides are inserted opposite OG and two 
products of its further oxidation, Gh and Sp, and whether these three lesions can be 
efficiently bypassed by RT polymerases. Having in mind that the long-term goal of this 
project is mapping products of guanine oxidation in RNA, in this chapter we focused on 
identifying the sequencing signatures for OG, Gh, and Sp. A more detailed introduction 
into this topic was given in Chapter 3. 
 
Materials and methods 
Oligomer synthesis. The RNA and DNA oligonucleotides were synthesized by the 
core facilities at the University of Utah using standard solid-phase synthesis protocols. The 
RNA templates containing OG were synthesized using the commercially available rOG 
phosphoramidite (ChemGenes, Wilmington, MA). The RNA strands were synthesized 
with a 3` dT to maximize the solid-phase synthesis yield of the modified RNA strands; the 
added dT will not impact cDNA synthesized during reverse transcription. All 
oligonucleotides were purified via an analytical anion-exchange HPLC and dialyzed 
against ddH2O. Oligonucleotides containing Gh and Sp were synthesized by Aaron 
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Fleming as previously described in Chapter 3. Oligomers containing Sp were purified and 
studied in this chapter as a mixture of diastereomers because the lengths of the RNA 
templates were too long resulting in the isomers eluting as a single peak from the HPLC 
column. 
Labeling of the DNA primer. Monitoring the efficiency of reverse transcription and 
deletion bypass was achieved via polyacrylamide gel electrophoresis (PAGE) wherein the 
DNA primer was 5’ end-labeled with 32P following a procedure adopted from the literature1 
using T4 polynucleotide kinase (New England Biolabs, Ipswich, MA.) and [γ-32P] ATP 
(PerkinElmer, Waltham, MA.). 
Reverse transcription. Before reverse transcription, all samples were annealed by 
heating 7 µL of aqueous solution containing 1.32 pmol (132 nM in a final volume of 10 
µL) of RNA template and 1.2 pmol (120 nM in 10 µL) DNA primer including ~30,000 
cpm 32P-labeled strand, 750 nmol KCl (75 mM in 10 µL), and 500 nmol Tris-HCl pH 8.3 
buffer (50 mM in 10 µL) to 95 °C for 5 min, and then incubating them at 55 °C for 5 min 
followed by cooling at 15 °C for another 10 min. Then 3 μL of freshly made stock solution 
containing 30 nmol MgCl2, 100 nmol DTT, 5 nmol of each dNTP, and 100 units 
SuperScript III was added to the annealed RNA-DNA duplex to give final concentrations 
of 3 mM MgCl2, 10 mM DTT, 500 μM of each dNTP (1 mM dATP and 500 μM other 
dNTPs for OG-A, and Sp-A), and 10 U/μL of SuperScript III (or MMLV RT of the same 
concentration) in the final volume of 10 μL. Reaction mixtures were incubated for 40 min 
at room temperature (rt, ~25 °C), 35 °C, 37 °C, 40 °C, 45 °C, or 50 °C. Then to quench the 
reaction, an equal volume of 2x gel loading buffer (8 M urea, 0.01% xylene cyanole, 0.01% 
bromphenol blue, x1 TBE buffer) were added and the mixture was heated to 95 °C for 10 
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min. About 10 µL of the resulting solution were analyzed on 20% denaturing PAGE. Gels 
were stored for 12-18 h with a storage phosphor screen that was then scanned using a 
phosphoimager. The resulting images were analyzed using ImageJ2 software.2-3 All 
reactions have been performed using C1000 Touch thermal cycler (BioRad, Hercules, CA). 
Reverse transcription-polymerase chain reaction. Samples for the reverse 
transcription have been prepared as described in the previous section on the scale from 10 
to 40 μL without addition of 32P-labeled primer. Reverse transcription has been performed 
at 45 °C for 40 min. Upon completion of the reaction samples were incubated at 93 °C for 
10 min to facilitate degradation of RNA template. 
For PCR amplification of cDNA, 2 μL of RT reaction mixture were mixed with 48 
μL of freshly made stock solution containing the remaining components required for PCR 
reaction to give final concentrations of 700 nM forward primer (including ~100,000 cpm 
32P labeled primer for the samples analyzed by PAGE), 700 nM reverse primer, 400 μM of 
each dNTP, 1x ThermoPol reaction buffer (20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM 
KCl, 2mM MgSO4, 0.1% Triton X-100, pH 8.8, New England Biolabs, Ipswich, MA), and 
2.5 U/50 μL Taq DNA polymerase (New England Biolabs, Ipswich, MA) in 50 μL. Then 
samples containing 32P labeled forward primer were denatured by heating with gel loading 
buffer and 15 μL of this mixture were analyzed on acrylamide gel as described in the 
previous section. Nonradioactive samples were analyzed via agarose gel electrophoresis. 
PCR conditions are described in results and discussion section of this chapter, all reactions 
have been performed using C1000 Touch thermal cycler (BioRad). Negative PCR no 
template control (NTC) was done with each PCR mixture. 
Sanger and Illumina sequencing. Samples for Sanger sequencing were prepared by 
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purifying nonradioactive PCR products using QIAquick PCR purification kit (Qiagen, 
Hilden, Germany) following protocol suggested by manufacturer. Then 5-22 ng of purified 
PCR product and 3 pmol of sequencing primer were submitted for sequencing at the DNA 
Sequencing Core Facility, University of Utah. Concentration of dsDNA was calculated in 
ng/μL based on absorbance at 260 nm. 
Samples for Illumina sequencing were prepared by purifying nonradioactive PCR 
products via reverse-phase HPLC on Microsorb 100-5 C18 column (150 x 2 mm) while 
running a linear gradient 5-60% B over 80 min at 0.7 mL/min flow rate (solvent A = 20 
mM NH4AcO pH 7, solvent B = MeCN). Then fractions containing PCR product were 
combined and submitted to High Throughput Genomics Core Facility, University of Utah. 
 
Results and discussion 
Oligonucleotide design. The next step after studying which nucleotides are inserted 
opposite OG, Gh, and Sp is investigating in more detail the sequencing signals from these 
lesions. For this purpose, five longer 35-37 nucleotide (nt) RNA templates containing one 
of the studied lesions in the middle were used (Figure 4.1). These templates were designed 
by choosing a sequence of 3-5 nts containing a lesion in the second position from the 3’ 
end and adding sequences of PCR primers to the 3’ and 5’ end of it. Recommended length 
for primers for PCR is 18-30 nts with a GC-content of 40-60%, but the primers used for 
amplification in this case were just 16 nt-long and significantly more GC-rich (75%) to 
increase their melting temperature. Solid-phase synthesis of RNA still remains quite a 
challenging task, especially when nonstandard phosphoramidites like OG are used, and 


















Figure 4.1. Sequences of RNA templates. Underlined nucleotides correspond to variable 
region in final RT-PCR product; nucleotides that are not underlined belong to primer 
regions. Blue markings indicate changes compared to 2L template. 
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40 nts.4 Thus, the rationale behind using shorter PCR primers was to shorten RNA  
templates as much as possible. Design of these templates allowed amplification of cDNA 
via PCR upon reverse transcription (RT-PCR). Two different sets of primers were used for 
RT-PCR amplification of these templates. The first set was designed for next-generation 
sequencing (NGS) and consisted of two 16-mer DNA primers for PCR, P16 and P16r, 
former has also been used for RT (Figure 4.2 A). The second set was designed for Sanger 
sequencing and consisted of two PCR primers, 20-mer forward primer (P20S) and 16-mer 
reverse primer (P16r), and 80-mer DNA primer (P80) used for RT (Figure 4.2 B). The long 
RT primer hybridized to the RNA template via the same 16 bases on its 3’-end as the one 
used for NGS samples, and the only difference between them was a 64 nt-long 5’ overhang 
designed not to have secondary structure. During Sanger sequencing information from 50-
60 nucleotides just downstream of the primer binding site is lost. The reason for using such 
a long RT primer was to move the region of interest containing OG, Gh, or Sp outside of 
this sequencing dead-zone. The PCR forward primer has been designed to satisfy all 
requirements for Sanger sequencing primer (18-24 nts, 3’ GC-lock, 45-55% GC content, 
and 50-65 °C Tm) and has been used in this role. The PCR reverse primer was identical to 
the one used for NGS samples. While studying deletion bypass of Sp and Gh elongated 
versions of RT primers were used to imitate insertion of either A or G opposite these lesions 
(P18A, P18G, P82A, and P82G). 
RT-PCR condition optimization. Prior to submitting products of RT-PCR 
amplification of RNA templates for sequencing conditions for both reverse transcription 
and PCR were optimized. For this purpose, reverse transcription has been conducted at rt, 







Figure 4.2. Schematic representation of RT-PCR with two different sets of primers. RT-
PCR products amplified using a short RT primer (A) were used for gel analysis and 
Illumina sequencing, while RT-PCR that originated from RT with longer primer (B) were 
used for Sanger sequencing. Nucleotides marked in green are identical to the PCR forward 
primer, the ones marked in blue – to the PCR reverse primer.  
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were then resolved via PAGE and the amount of fully extended cDNA was quantified 
(Figure 4.3). Unsurprisingly the RNA template containing OG gave the greatest amount of 
full extension product followed by Gh- and Sp-containing templates. The presence of 
hydantoin lesions in the template caused a significant amount of polymerization arrest at 
the stage of insertion of a base opposite the lesion, as well as two bases following it (bands 
P+1, P+2, and P+3 correspondingly). These results were in perfect agreement with the 
results reported in Chapter 3. A minor trend of increasing yield of fully extended cDNA 
with the increase in reaction temperature was observed for Gh- and Sp-containing 
templates, while for OG-containing template the highest yield was observed at 37 °C and 
it decreased slightly from 37 °C to 50 °C. Hence, we chose a temperature of 45 °C for 
conducting all future RT reactions. 
For optimization of PCR conditions cDNA was amplified using a different number 
of PCR cycles (15-20), annealing temperatures (50-57 °C), and extension conditions (0.5-
1 min at 68-72 °C). The main criteria for evaluation of PCR conditions were amount of 
PCR product and absence of amplification in negative NTC (data not shown). The final 
conditions used for PCR were: 18 cycles, 30 s denaturation at 95 °C, 30 s annealing at 57 
°C, and 1 min extension at 72 °C. 
Sample preparation for Illumina sequencing. To quantify the insertion ratio of A 
and C opposite OG and G and A opposite Sp and Gh we performed RT-PCR amplification 
of the 2L template using short (P16) RT primer. Apart from quantifying the insertion ratio 
under the standard RT conditions, I also wanted to test to what extent sensitivity of 
detection of these bases can be improved by increasing the concentration of the dNTP 








Figure 4.3. PAGE analysis of reverse transcription products at different reaction 
temperatures.  
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shifting insertion of a mixture of two bases toward just one of them and by doing so 
improve the noise to signal ratio that will be crucial once this sequencing method is applied 
to biological systems. For this purpose, there were two additional samples submitted for 
Illumina sequencing, “OG-A” and “Sp-A,” in case of these samples the RT reaction was 
conducted with a twice higher concentration of dATP. We also considered trying to 
channel insertion opposite Gh or Sp towards G, but increasing the dGTP concentration in 
the reaction mixture would likely have led to an increase in the amount of G insertion 
opposite T. An increase in reverse transcription errors upon an increase in single dNTP 
concentration has to be separately studied to evaluate whether this approach can be useful. 
RT-PCR products synthesized for Illumina sequencing were tested via PAGE (Figure 4.4) 
and purified via reverse-phase HPLC (Figure 4.5 A). Based on the gel, the PCR yielded 
close to 50% of amplification product for OG and Sp and ~70% for Gh. Interestingly, RT-
PCR of the templates containing both hydantoin lesions produced about 1:1 ratio of the 
full-length and 2 nts shorter amplification products. This phenomenon is further 
investigated in the next section of the current chapter. The main reason for using HPLC 
was insufficient length of PCR amplicons for purification with standard PCR cleanup kits. 
All fractions coming between 2 min and 81 min were collected and then their absorbance 
spectra were analyzed. Three peaks on the chromatogram in Figure 4.5 were found to have 
absorbance maximum at 260 nm: 2 min, 10 min, and 11 min. These fractions were further 
tested by performing their PCR amplification (Figure 4.5 B). The peak at 2 min most likely 
contained dNTPs and unextended primers and gave smeared bands on the agarose gel upon 
amplification due to their concentrations exceeding the optimal ones for PCR. The peaks 








Figure 4.4. PAGE analysis of RT-PCR products originating from 2L templates. Lanes 









Figure 4.5. Purification of RT-PCR products by HPLC and fraction analysis. (A) Typical 
HPLC trace, red box marks peaks corresponding to PCR product. (B) Agarose gel showing 
products of PCR amplification of different fractions collected from HPLC. 
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template for PCR. Hence, these two fractions for each of the five samples (OG, Gh, Sp, 
OG-A, and Sp-A) were combined together and submitted for Illumina sequencing. 
Deletion bypass of Sp and Gh. Previously our lab reported that primers extended 
just until the position occupied by Gh in the template show improved resistance to 
proofreading by E. coli DNA polymerase I Klenow fragment when base positioned 
opposite Gh can form a stable base pair with the next nucleotide.5 This together with the 
previous observation that polymerization based on Gh-containing templates produces a 
significant amount of n-1 primer extension product6 led to a hypothesis that after insertion 
of A or G opposite of Gh this lesion can be twisted out of the DNA helix if this leads to 
formation of a stable A-T or G-C base pair (Figure 4.6). To test whether this phenomenon 
was responsible for the appearance of shorter RT-PCR product when RNA templates 
contained Gh or Sp (Figure 4.4), we studied the dependence of the ratio between full-length 
and truncated PCR products on two factors: 
a) identity of the base inserted opposite the hydantoins 
b) nucleotide sequence 5’ downstream from the lesion position in the template. 
For this purpose, we chose to use Sanger sequencing of long RT-PCR products in 
combination with PAGE analysis of the short RT-PCR products because of its lower cost 
and faster sample turnover. Apart from the RNA template 2L used in the previous studies, 
we synthesized OG-, Gh-, and Sp-containing versions of another four template strands 
(Figure 4.1). These templates had different amounts of purine bases between the site 
occupied by one of the lesions and the next pyrimidine base that can form a stable base 
pair with A or G inserted opposite Sp or Gh. This design allowed study of the efficiency 



















Figure 4.6. Mechanism of deletion bypass of Gh and Sp. 
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nt- and 80 nt-long RT primers (P16 and P80 on Figure 4.1) for the reverse transcription, 
we used their longer versions extended by 2 nucleotides to imitate 100% insertion of either 
A or G (P18A, P18G, P82A, and P82G of Figure 4.1) and to study efficiency of deletion 
bypass separately for A and G insertion. 
Prior to studying deletion bypass of Sp and Gh, we tested whether the system 
designed can be used for Sanger sequencing. To do so, we reverse transcribed 2L-OG 
template using the P80 primer, PCR-amplified cDNA using P20S and P16r primers, and 
submitted the purified PCR product for sequencing with the P20S primer. Sequencing 
chromatograms, as well as gel data showing efficiency of RT and subsequent PCR, are 
presented on Figure 4.7. Based on the PCR product gel analysis and Sanger sequencing 
trace, the designed system can successfully be used to obtain an ensemble sequencing 
information on RT-PCR products. However, it should be noted that errors introduced 
during solid-phase synthesis of the 80 nt-long primer cause appearance of a noticeable 
amount n-1 bands on sequencing chromatograms and make PAGE analysis of RT products 
impossible due to very diffuse bands. 
For comprehensive investigation of deletion bypass of Sp and Gh, we employed 
the strategy schematically represented on Figure 4.8. First, we conducted RT with one of 
the short primers (P16, P18A, or P18G) and subsequently PCR-amplified the cDNA with 
P16 and P16r primers. For the gel analysis of the RT products, we used 32P-labeled primers 
during the RT reaction, while for gel analysis of the RT-PCR products, RT was done with 
nonradioactive primers and only during PCR 32P-labeled P16 primer was added. Next, we 
conducted RT-PCR amplification of all samples using long RT primers (P80, P82A, or 




Figure 4.7. PAGE (A) and Sanger sequencing (B) data for products of RT or RT-PCR 
originating from 2L-OG template. On the gel P20S marks position of PCR primer. On the 

















Figure 4.8. Schematic representation of the workflow. * indicates radiolabeled species. 
143 
quantification of the amount of full-length and 1-3 nts shorter PCR products based on 
PAGE analysis and to test whether formation of shorter PCR products is caused by 
expulsion of hydantoin bases from the RNA-DNA helix using Sanger sequencing data. The 
RT and PCR reactions were conducted under conditions previously optimized for samples 
prepared for Illumina sequencing. Results of this study are presented on Figures 4.9, 4.10, 
4.12-18 and Table 4.1. On the figures the samples are labeled as NRRR-BB, where RRR-
BB is a previously used identifier for RNA template used for RT and oxidized lesion that 
this template contains and N, when it is added, indicates that reverse transcription was done 
using 2 nts longer primer with N base at the 3’-end of the primer positioned opposite OG, 
Gh, or Sp. 
Gels on Figures 4.9 and 4.10 show the efficiency of primer extension for all five 
templates with three different primers. Samples extended using P16 show efficiency of 
insertion and extension under running start conditions, while samples extended using P18N 
primers show efficiency of extension under standing-start conditions. The presence of both 
Sp and Gh causes a dramatic decrease polymerase activity when extension is conducted 
under the standing-start vs. the running-start conditions. This behavior is typical for 
mismatches7 and is likely caused by the fact that neither Sp nor Gh form stable base pairs 
leading to end fraying at the 3’-end of the primer and affecting the ability for the 
polymerase to recognize the substrate and initiate primer extension, the same effect is 
thought to be responsible for DNA polymerase proofreading.8 To test whether this effect 
is specific for Gh- and Sp-containing templates, we ran RT of 1L-OG and 2L-OG templates 
(Figure 4.11). Indeed, when primer extension under standing-start conditions is conducted 











Figure 4.9. PAGE analysis of cDNA obtained by reverse transcribing Gh-containing 











Figure 4.10. PAGE analysis of cDNA obtained by reverse transcribing Sp-containing 









Figure 4.11. PAGE analysis of cDNA obtained by reverse transcribing OG-containing 
templates. Red arrows indicate position of full extension product on the gel. 
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prominent when compared to extension with the P16G primer or any templates having 
hydantoin lesions. Notably, reverse transcription of both 2L-Gh and 2L-Sp templates under 
the standing-start conditions leads to the largest amount of truncated products and the 
smallest amount of unextended primer. In case of the 2L-Sp template, reverse transcription 
also yields the lowest amount of full-length cDNA. Improved efficiency of RT initiation is 
indicative of better recognition of primer-template duplexes involving 2L template by 
polymerase, while the abundance of produced truncated products shows that for some 
reason polymerase-substrate interactions get disrupted once primer growth is initiated. Due 
to the fact that RT leads to formation of numerous truncated and overextended products it 
is impossible to estimate efficiency of deletion bypass based on these gels. 
Measurement of a ratio between full-length and deletion cDNA was done based on 
PAGE analysis of RT-PCR products (Figures 4.12 and 4.13). These measurements were 
repeated 3 times for all templates with Sp and 5 times for templates with Gh; the results 
are summarized in Table 4.1. Major discrepancies in efficiency of deletion bypass between 
templates with Sp and Gh are highlighted in red. Additional RNA degradation control was 
added to the gel on Figure 4.12. Taq polymerase is known to be able to use RNA as a 
template9 and the purpose of this control was to check whether any of the observed RT- 
PCR products originated from this. To test this, we conducted the RT reaction without the 
enzyme followed by a standard heating step that we used to degrade the RNA template and 
attempted to amplify degraded RNA template via PCR. This control was indistinguishable 
from the negative NTC meaning that none of the bands on the gel originate from direct 
RNA amplification. For templates 1L and 2L, the presence of Gh led to formation of 





























Table 4.1. Results of quantification of fraction of deletion bypass products on 
Figures 4.12 and 4.13. 
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to Sp, but because of a higher ratio of G inserted opposite Gh this did not result in change 
in efficiency of deletion bypass under standing-start conditions when both nucleotides can 
be inserted. For the same reason, 2LG and 3L templates containing Gh showed formation 
of a larger amount of deletion product under running-start conditions while individual 
insertion of A and G yielded a similar amount of deletion product. Interestingly, RT-PCR 
of 2LU template with all three used primers yielded similar results for both Sp and Gh. The 
data received from Sanger sequencing were in good alignment with the data from the gels 
(Figures 4.14-18) with a few exceptions (2LG-Gh on Figure 4.16, 2LU-Gh, G2LU-Gh, 
2LU-Sp, and G2LU-Sp on Figure 4.17) where the amount of deletion bypass product was 
underestimated by Sanger sequencing. 
Overall, the efficiency of deletion bypass based on PAGE and Sanger sequencing 
data appeared to be highly dependent on the nature of bases 5’ downstream from the lesion 
position. The highest amount of deletion RT-PCR product was observed for the 2L 
template. However, the formation of this product does not appear to be driven just by 
formation of a stable G-C base pair (G2L samples) because large amounts of deletion 
product were observed even when A was inserted opposite Gh or Sp (A2L samples). 
Deletion bypass in this case occurs through formation of an A-C base pair that becomes 
stable only at low pH when N1 of A is protonated.10 Apart from this anomaly, deletion 
bypass becomes prominent only when a stable locking base pair can be formed (G-C for 
1L, 2LG, and 3L and A-U or G-U for 2LU). Interestingly, the efficiency of deletion bypass 
also depends on the nature of the purine base that is expelled from the duplex together with 
Gh or Sp. When this base is an A (2L samples), the deletion product amount is significantly 








Figure 4.14. Deletion bypass of hydantoin lesions in 1L template. (A) Sanger sequencing 
data for RT-PCR products originating from 1L template containing Gh or Sp. (B) 
Mechanism of deletion product formation. Black arrow indicates position occupied by 








Figure 4.15. Deletion bypass of hydantoin lesions in 2L template. (A) Sanger sequencing 
data for RT-PCR products originating from 2L template containing Gh or Sp. (B) 
Mechanism of deletion product formation. (C) Structures of protonated and unprotonated 








Figure 4.16. Deletion bypass of hydantoin lesions in 2LG template. (A) Sanger sequencing 
data for RT-PCR products originating from 2LG template containing Gh or Sp. (B) 
Mechanism of deletion product formation. Black arrow indicates position occupied by 








Figure 4.17. Deletion bypass of hydantoin lesions in 2LU template. (A) Sanger sequencing 
data for RT-PCR products originating from 2LU template containing Gh or Sp. (B) 
Mechanism of deletion product formation. Black arrow indicates position occupied by 








Figure 4.18. Deletion bypass of hydantoin lesions in 3L template. (A) Sanger sequencing 
data for RT-PCR products originating from 3L template containing Gh or Sp. (B) 
Mechanism of deletion product formation. Black arrow indicates position occupied by 
lesion in the template. 
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slightly increased amount of n-1 deletion product with P82G and P18G indicative of 
deletion bypass via formation of G-G base pair; this effect was more prominent for Sp. 
Another interesting detail is that efficiency of deletion bypass increases from the 1L 
template to the 3L template. This is highly unusual behavior because deletion bypass in the 
second case requires formation of extrahelical loop containing 3 nucleotides instead of just 
one nucleotide in the first case. To test whether the observed trend for deletion bypass 
efficiency of Sp-R and Gh-R (R=purine base A or G) base pairs is similar to mismatched 
base pairs, we used the same five templates containing OG. These templates were reverse-
transcribed using P80G (enforces G-G mismatch at the growing end of the primer) and P80 
(control) primers and PCR amplified. The results of Sanger sequencing of the RT-PCR 
products are presented on Figures 4.19 and 4.20. In this case, the only template that led to 
formation of a significant amount of deletion product was 1L-OG (~70% n-1 product). This 
confirmed our initial assessment that deletion bypass of Sp and Gh is highly unusual and 
is unlikely to be driven only by formation of stable base pair at the 3’ end of the growing 
primer. 
We hypothesized that unusual susceptibility of hydantoin-containing templates can 
be caused by the specific interactions that the extrahelical bases form with the enzyme.11 
To do so, we first checked whether SuperScript III has point mutations compared to the 
parent MMLV RT in proximity to the region where the extrahelical bases would be 
positioned. The Protein Data Bank (PDB) contains only crystal structures of MMLV RT 
without its substrate.12 However, there is a crystal structure of RT-substrate complex for 
an RT from a Xenotropic murine leukemia virus-related virus (XMRV), a virus derived 






Figure 4.19. Sanger sequencing data for RT-PCR products originating from reverse 
transcription of OG-containing templates with P80 primer. Black arrow indicates position 






Figure 4.20. Sanger sequencing data for RT-PCR products originating from reverse 
transcription of OG-containing templates with P82G primer. Black arrow indicates 
position occupied by OG in the template. 
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crystal structure of MMLV RT12 (4MH8 in PDB) and we found these two proteins to have 
identical structures and sequences in the region of interest (positions 116-127 and 190-197 
in both proteins, Figure 4.21 A). Positions of point mutations introduced in SuperScript III 
RT compared to MMLV RT are known from the patent.14 Three of these point mutations 
are in close proximity to the region where extrahelical bases would reside during the initial 
primer slippage required for deletion bypass (Figure 4.21 B). Next, we conducted RT-PCR 
amplification of the 2L-Gh template using MMLV RT at 37 °C for RT. When RT-PCR 
products were resolved on the gel we detected a significant amount of deletion bypass 
product only when G was inserted opposite Gh (Figure 4.21 C). Apart from the absence of 
the anomalous product of deletion bypass when A was inserted opposite Gh, the overall 
efficiency of deletion bypass was lower for MMLV RT. These data confirm our hypothesis 
that deletion bypass of Sp and Gh is driven in part by interaction of extrahelical bases and 
enzyme active site and show that point mutations introduced in SuperScript III enzyme 
promote deletion bypass at least in the case of templates containing hydantoin lesions. 
Considering that RT with MMLV RT was conducted at lower temperature (40 °C instead 
of 45 °C), we investigated whether temperature affects efficiency of deletion bypass. The 
2L-Gh template was used for this experiment. We found that the ratio between n-2 and 
full-length products in the studied temperature range (35-50 °C) changes only when A is 
inserted and deletion bypass requires formation of A-C base pair (Figure 4.22). At the same 















Figure 4.21. Dependence of deletion bypass on reverse transcriptase. (A) Fragment of 
aligned sequences of XMRV RT (4HKQ)13 and MMLV RT (4MH8).12 (B) Fragment of 
crystal structure of XMRV RT surrounding presumed position of extrahelical bases after 
the initial primer slippage (red circle).13 Positions of mutated amino acids in SuperScript 
III are marked in blue in the crystal structure and underlined in aligned sequences. (C) 
PAGE analysis of RT and RT-PCR products obtained by using MMLV RT. Fractions of 











Figure 4.22. Dependence of deletion bypass efficiency on the temperature. (A) PAGE 
analysis of RT products at different reaction temperatures. Red arrow indicates position of 
full extension product on the gel. (B) PAGE analysis of RT-PCR products at different RT 




In this chapter, we laid groundwork for mapping oxidized lesions in RNA. First, 
we did the required preliminary work for quantification of the amount of different 
nucleotides inserted opposite OG, Gh, and Sp with Illumina sequencing. These data would 
be important for estimation of sensitivity of this method and its further optimization. Next, 
we confirmed the previously proposed mechanism of deletion bypass of Gh and Sp in 
template strand and studied this phenomenon. The frequency of deletion bypass appeared 
to be highly dependent on the sequence context and on the identity of the RT enzyme, while 
unaffected by reaction temperature. Understanding of this phenomenon would be crucial 
for analysis of sequencing signature of Gh and Sp lesions. However, the frequency at which 
deletion bypass occurs can significantly complicate analysis of NGS data and hinder our 
ability to map hydantoin lesions. In addition to that, we also confirmed the identity of the 




The work presented in this dissertation was aimed at mapping several products of 
guanine oxidation in RNA. Several important steps were taken toward reaching this goal. 
We identified that RT enzymes recognize these lesions and can insert canonical DNA bases 
opposite them. This produces localized characteristic mutation signature in cDNA that can 
be amplified using standard RT-PCR protocols. And PCR amplification allows working 
with significantly smaller amount of RNA extracted from cells. The next goal of this 
project is attempting to map OG in RNA. All three guanine oxidation products studied here 
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are very low-abundance base modifications. Among them OG occurs with the highest 
frequency (one OG per ~106 nts in DNA15-16 and 105-106 nts in RNA15, 17-18; one Gh or Sp 
per ~108 nts in DNA15) and thus presents an easier target for detection. Mapping positions 
of such infrequent base modification present significant challenge and can only be 
accomplished by using NGS methods.19-20 Prior to sequencing, we would have to optimize 
the conditions for two steps preceding sequencing library preparation, fragmentation of 
cellular RNA, and enrichment of the strands containing the OG (Figure 4.23).  
There are three main ways of cutting RNA into random fragments of ~150 nts that 
can be analyzed by Illumina sequencing: endonuclease digestion, mechanical shearing, and 
chemical cleavage. The first one uses RNAse III digestion of RNA, fragments generated 
by this method are 3’ and 5’ phosphorylated that makes them ready for adapter ligation 
without additional processing. The drawback of this method is that enzymatic cleavage is 
biased and leads to gaps and pile-ups (unequal representation of specific regions) in the 
final sequencing data.21 The second approach uses an acoustic or hydrodynamic wave to 
break DNA or RNA apart. Mechanical shearing is typically a method of choice for DNA 
fragmentation; its main appeal is that it allows production of uniform fragments with 
minimal bias and without additional purification steps or risk of contaminating sequencing 
samples with the enzymes or chemicals that can negatively impact the sequencing read 
quality. However, mechanical shearing leads to local formation of free radicals and 
hydrogen peroxide that can introduce oxidative damage at the ends of RNA or DNA 
fragments.22 Due to this fact, DNA repair enzymes are typically included in the enzyme 
mixtures aimed at production of blunt-end dsDNA fragments before adapter ligation; the 




Figure 4.23. Application of OG-Seq for mapping oxidation sites in RNA. (A) Schematic 
representation of OG-Seq workflow adopted for RNA sequencing. (B) Selective oxidation 
of OG in the presence of primary amine-terminated biotin.23 
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during fragmentation.23 In addition to that, mechanical fragmentation method is not 
completely unbiased; its efficiency depends on sequence and, more importantly for RNA, 
secondary structure.24 The last method exploits the susceptibility of ssRNA to backbone 
cleavage in solutions of divalent metal ions, typically RNA fragmentation is done at 70-95 
°C in the presence of magnesium or zinc.25 Currently most  RNA Illumina sequencing is 
done using metal ion cleavage. This approach allows cleaving RNA above its melting 
temperature removing potential bias for single-stranded regions. The negative aspect of 
this method is deamination of RNA bases (primarily C) induced at high temperature.26 
Before applying this method to OG-containing RNA we would have to optimize conditions 
for fragmentation (time, temperature, and concentrations) and subsequent purification to 
minimize sample losses and number of sequencing errors introduced in this step.  
Enrichment of RNA strands containing the modification of interest is usually 
accomplished by immunoprecipitation with specific antibodies. However, it has been 
shown that antibodies that are currently available for OG do not have sufficient binding 
affinity or selectivity for effective enrichment.23 An alternative enrichment approach is 
using nonantibody proteins that can bind OG or chemical ligation followed by affinity 
purification (AP). Several proteins are known to bind OG in RNA: polynucleotide 
phosphorylase (PNPase),27-28 Y box-binding protein 1 (YB-1),29 splicing factor 3B subunit 
4 (SF3B4),30 heterogeneous nuclear ribonucleoprotein D0 (HNRNPD),30 heterogeneous 
nuclear ribonucleoprotein C (HNRNPC),30 DAZ-associated protein 1 (DAZAP1),30 and 
ELAV-like protein 1 (ELAVL1).30 Affinity or selectivity of OG binding by any of these 
proteins is unknown and has to be tested if we decide to use them for enrichment. AP of 
OG-containing oligonucleotides has been described before.23 In this approach OG is 
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selectively oxidized to an electrophilic intermediate that then is trapped by a primary amine 
nucleophile present in the reaction mixture.31 In this case, OG in RNA is converted to the 
biotin-adduct of Sp that allows selective extraction by AP (Figure 4.23). Before applying 
this method to RNA, we would have to study the behavior of RT enzymes when they 
encounter bulky Sp-biotin adducts and optimize RT reaction conditions. 
For interpretation of sequencing data, we would additionally need to quantify OG 
in RNA. This step is required because of the potential underestimation of the OG amount 
in RNA due to bias of RNA fragmentation (even chemical method of RNA fragmentation 
has been found to have some bias of unknown origin)21 and RT (as we have shown in 
Chapter 3 introduction of OG, Gh, or Sp in RNA decreases efficiency of RT). We have 
considered two methods that potentially can be used for this purpose. The first one utilizes 
a similar approach to the one described for AP, where OG is selectively oxidized in the 
presence of a primary amine that has a fluorophore attached to it.31 In this method, cellular 
RNA is immobilized on protamine-coated surface and after oxidation and subsequent 
elution of unbound fluorophore amount of OG in the sample is measured based on 
fluorescence intensity of bound fluorophore. The second method is an LC-MS approach 
where OG is quantified upon digestion of RNA to nucleosides.15  
Another direction of the future work is attempting to use different RT enzymes. 
Two main concerns about using SuperScript III for future work is its relatively high error 
rate (1 in 32,000 bases)32 and the absence of consolidated sequencing signature for Gh and 
Sp due to the prevalence of deletion bypass. Considering the low abundance of OG (below 
SuperScript III error rate) and potential necessity of mapping it as an adduct of Sp, these 
drawbacks can be detrimental for the success of sequencing OG in RNA. A potential 
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solution for both problems is using high fidelity RT enzymes like AccuScript, Transcriptor, 
PrimeScript, PyroScript, or TGIRT. The fidelity of RT can also be increased by addition 
of DNA 3’-5’ exonucleases. This approach imitates proofreading during DNA replication, 
and its validity has to be tested for RT past oxidized lesions.33 
The most obvious target for mapping OG is ribosomal RNA (rRNA). Unlike DNA, 
about 90% of cellular RNA is consolidated in just a few rRNA molecules (5S, 16S, and 
23S in prokaryotes and 5S, 5.8S, 18S, and 28S in eukaryotes).34 This means that there are 
up to 10 million copies of each of rRNA in mammalian cells,35 and up to 70 thousand 
copies in bacteria.36 Such high abundance would greatly simplify isolation of the amount 
of RNA required for sequencing. Additionally, rRNA has been found to be one of the major 
targets of iron-mediated oxidation in neuron cells, which makes it a promising candidate 
for mapping the distribution of OG.37 Therefore, the first RNA target to sequence for OG 
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